activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1790372	CHEMBL856398	Percent residual activity, relative to control, of NEK7 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	56.0	CHEMBL4849	Homo sapiens	Activity	%	56.0
	1790372	CHEMBL856398	Percent residual activity, relative to control, of NEK7 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	56.0	CHEMBL4849	Homo sapiens	Activity	%	56.0
	1790426	CHEMBL856398	Percent residual activity, relative to control, of NEK7 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	58.0	CHEMBL4849	Homo sapiens	Activity	%	58.0
	2147328	CHEMBL922013	Activity of human NEK7 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	99.0	CHEMBL4849	Homo sapiens	Activity	%	99.0
Not Active	2302182	CHEMBL950851	Inhibition of NEK7 at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL4849	Homo sapiens	INH		
	2470296	CHEMBL987216	Inhibition of NEK7 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4849	Homo sapiens	INH	%	10.0
	2476586	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	27.9	CHEMBL4849	Homo sapiens	Activity	%	27.9
Not Evaluated	2476789	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2478628	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4849	Homo sapiens	Activity		
	2478831	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	13.45	CHEMBL4849	Homo sapiens	Activity	%	13.45
	2479561	CHEMBL988952	Binding affinity to human NEK7	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	>	Kd	nM	40000.0	CHEMBL4849	Homo sapiens	Kd	nM	40000.0
Not Evaluated	2479686	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2480685	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2577307	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2577510	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2593512	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2593715	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2593981	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2594924	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2595127	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2595193	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2596324	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2597593	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Evaluated	2597796	CHEMBL993450	Binding affinity to human NEK7 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4849	Homo sapiens	Activity		
	2635889	CHEMBL1003319	Inhibition of NEK7 at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	=	Residual_activity	%	100.0	CHEMBL4849	Homo sapiens	Residual_activity	%	100.0
	2635957	CHEMBL1003319	Inhibition of NEK7 at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	=	Residual_activity	%	100.0	CHEMBL4849	Homo sapiens	Residual_activity	%	100.0
	2636025	CHEMBL1003319	Inhibition of NEK7 at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	75.0	CHEMBL4849	Homo sapiens	Residual_activity	%	75.0
	2721668	CHEMBL1054300	Inhibition of NEK7 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	2894957	CHEMBL1063808	Binding constant for full-length NEK7	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894958	CHEMBL1063808	Binding constant for full-length NEK7	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894959	CHEMBL1063808	Binding constant for full-length NEK7	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894960	CHEMBL1063808	Binding constant for full-length NEK7	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894961	CHEMBL1063808	Binding constant for full-length NEK7	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894962	CHEMBL1063808	Binding constant for full-length NEK7	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894963	CHEMBL1063808	Binding constant for full-length NEK7	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	5600.0	CHEMBL4849	Homo sapiens	Kd	nM	5600.0
	2894964	CHEMBL1063808	Binding constant for full-length NEK7	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894965	CHEMBL1063808	Binding constant for full-length NEK7	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894966	CHEMBL1063808	Binding constant for full-length NEK7	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894967	CHEMBL1063808	Binding constant for full-length NEK7	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894968	CHEMBL1063808	Binding constant for full-length NEK7	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894969	CHEMBL1063808	Binding constant for full-length NEK7	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894970	CHEMBL1063808	Binding constant for full-length NEK7	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894971	CHEMBL1063808	Binding constant for full-length NEK7	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894972	CHEMBL1063808	Binding constant for full-length NEK7	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894973	CHEMBL1063808	Binding constant for full-length NEK7	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894974	CHEMBL1063808	Binding constant for full-length NEK7	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894975	CHEMBL1063808	Binding constant for full-length NEK7	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894976	CHEMBL1063808	Binding constant for full-length NEK7	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894977	CHEMBL1063808	Binding constant for full-length NEK7	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894978	CHEMBL1063808	Binding constant for full-length NEK7	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894979	CHEMBL1063808	Binding constant for full-length NEK7	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894980	CHEMBL1063808	Binding constant for full-length NEK7	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894981	CHEMBL1063808	Binding constant for full-length NEK7	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894982	CHEMBL1063808	Binding constant for full-length NEK7	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894983	CHEMBL1063808	Binding constant for full-length NEK7	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894984	CHEMBL1063808	Binding constant for full-length NEK7	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894985	CHEMBL1063808	Binding constant for full-length NEK7	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894986	CHEMBL1063808	Binding constant for full-length NEK7	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894987	CHEMBL1063808	Binding constant for full-length NEK7	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894988	CHEMBL1063808	Binding constant for full-length NEK7	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894989	CHEMBL1063808	Binding constant for full-length NEK7	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	4500.0	CHEMBL4849	Homo sapiens	Kd	nM	4500.0
	2894990	CHEMBL1063808	Binding constant for full-length NEK7	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	3200.0	CHEMBL4849	Homo sapiens	Kd	nM	3200.0
	2894991	CHEMBL1063808	Binding constant for full-length NEK7	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	4100.0	CHEMBL4849	Homo sapiens	Kd	nM	4100.0
	2894992	CHEMBL1063808	Binding constant for full-length NEK7	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894993	CHEMBL1063808	Binding constant for full-length NEK7	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2894994	CHEMBL1063808	Binding constant for full-length NEK7	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	2903286	CHEMBL1060150	Percentage NEK7 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	111.0	CHEMBL4849	Homo sapiens	Activity	%	111.0
	2903287	CHEMBL1060150	Percentage NEK7 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	86.0	CHEMBL4849	Homo sapiens	Activity	%	86.0
	2903288	CHEMBL1060150	Percentage NEK7 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	99.0	CHEMBL4849	Homo sapiens	Activity	%	99.0
	2903289	CHEMBL1060129	Percentage NEK7 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	108.0	CHEMBL4849	Homo sapiens	Activity	%	108.0
	2903290	CHEMBL1060129	Percentage NEK7 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	99.0	CHEMBL4849	Homo sapiens	Activity	%	99.0
	2903291	CHEMBL1060129	Percentage NEK7 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	84.0	CHEMBL4849	Homo sapiens	Activity	%	84.0
	2903292	CHEMBL1060129	Percentage NEK7 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	105.0	CHEMBL4849	Homo sapiens	Activity	%	105.0
	2903293	CHEMBL1060129	Percentage NEK7 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	101.0	CHEMBL4849	Homo sapiens	Activity	%	101.0
	2903294	CHEMBL1060129	Percentage NEK7 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	98.0	CHEMBL4849	Homo sapiens	Activity	%	98.0
	2903295	CHEMBL1060129	Percentage NEK7 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	104.0	CHEMBL4849	Homo sapiens	Activity	%	104.0
	2903296	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	93.0	CHEMBL4849	Homo sapiens	Activity	%	93.0
	2903297	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	120.0	CHEMBL4849	Homo sapiens	Activity	%	120.0
	2903298	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	96.0	CHEMBL4849	Homo sapiens	Activity	%	96.0
	2903299	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	84.0	CHEMBL4849	Homo sapiens	Activity	%	84.0
	2903300	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	2903301	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	98.0	CHEMBL4849	Homo sapiens	Activity	%	98.0
	2903302	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	86.0	CHEMBL4849	Homo sapiens	Activity	%	86.0
	2903303	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	70.0	CHEMBL4849	Homo sapiens	Activity	%	70.0
	2903304	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	110.0	CHEMBL4849	Homo sapiens	Activity	%	110.0
	2903305	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	93.0	CHEMBL4849	Homo sapiens	Activity	%	93.0
	2903306	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	86.0	CHEMBL4849	Homo sapiens	Activity	%	86.0
	2903307	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	94.0	CHEMBL4849	Homo sapiens	Activity	%	94.0
	2903308	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	111.0	CHEMBL4849	Homo sapiens	Activity	%	111.0
	2903309	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	103.0	CHEMBL4849	Homo sapiens	Activity	%	103.0
	2903310	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	114.0	CHEMBL4849	Homo sapiens	Activity	%	114.0
	2903311	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	106.0	CHEMBL4849	Homo sapiens	Activity	%	106.0
	2903312	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	109.0	CHEMBL4849	Homo sapiens	Activity	%	109.0
	2903313	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	97.0	CHEMBL4849	Homo sapiens	Activity	%	97.0
	2903314	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	96.0	CHEMBL4849	Homo sapiens	Activity	%	96.0
	2903315	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	105.0	CHEMBL4849	Homo sapiens	Activity	%	105.0
	2903316	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	103.0	CHEMBL4849	Homo sapiens	Activity	%	103.0
	2903317	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	99.0	CHEMBL4849	Homo sapiens	Activity	%	99.0
	2903318	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	97.0	CHEMBL4849	Homo sapiens	Activity	%	97.0
	2903319	CHEMBL1052109	Percentage NEK7 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	85.0	CHEMBL4849	Homo sapiens	Activity	%	85.0
	2903320	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	104.0	CHEMBL4849	Homo sapiens	Activity	%	104.0
	2903321	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	85.0	CHEMBL4849	Homo sapiens	Activity	%	85.0
	2903322	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	106.0	CHEMBL4849	Homo sapiens	Activity	%	106.0
	2903323	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	116.0	CHEMBL4849	Homo sapiens	Activity	%	116.0
	2903324	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	102.0	CHEMBL4849	Homo sapiens	Activity	%	102.0
	2903325	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	99.0	CHEMBL4849	Homo sapiens	Activity	%	99.0
	2903326	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	103.0	CHEMBL4849	Homo sapiens	Activity	%	103.0
	2903327	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	96.0	CHEMBL4849	Homo sapiens	Activity	%	96.0
	2903328	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	107.0	CHEMBL4849	Homo sapiens	Activity	%	107.0
	2903329	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	2903330	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	87.0	CHEMBL4849	Homo sapiens	Activity	%	87.0
	2903331	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	92.0	CHEMBL4849	Homo sapiens	Activity	%	92.0
	2903332	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	97.0	CHEMBL4849	Homo sapiens	Activity	%	97.0
	2903333	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	109.0	CHEMBL4849	Homo sapiens	Activity	%	109.0
	2903334	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	112.0	CHEMBL4849	Homo sapiens	Activity	%	112.0
	2903335	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	85.0	CHEMBL4849	Homo sapiens	Activity	%	85.0
	2903336	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	108.0	CHEMBL4849	Homo sapiens	Activity	%	108.0
	2903337	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	109.0	CHEMBL4849	Homo sapiens	Activity	%	109.0
	2903338	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	105.0	CHEMBL4849	Homo sapiens	Activity	%	105.0
	2903339	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	107.0	CHEMBL4849	Homo sapiens	Activity	%	107.0
	2903340	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	94.0	CHEMBL4849	Homo sapiens	Activity	%	94.0
	2903341	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	99.0	CHEMBL4849	Homo sapiens	Activity	%	99.0
	2903342	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	99.0	CHEMBL4849	Homo sapiens	Activity	%	99.0
	2903343	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	58.0	CHEMBL4849	Homo sapiens	Activity	%	58.0
	2903344	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	94.0	CHEMBL4849	Homo sapiens	Activity	%	94.0
	2903345	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	102.0	CHEMBL4849	Homo sapiens	Activity	%	102.0
	2903346	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	111.0	CHEMBL4849	Homo sapiens	Activity	%	111.0
	2903347	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	102.0	CHEMBL4849	Homo sapiens	Activity	%	102.0
	2903348	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	107.0	CHEMBL4849	Homo sapiens	Activity	%	107.0
	2903349	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	87.0	CHEMBL4849	Homo sapiens	Activity	%	87.0
	2903350	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	81.0	CHEMBL4849	Homo sapiens	Activity	%	81.0
	2903351	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	91.0	CHEMBL4849	Homo sapiens	Activity	%	91.0
	2903352	CHEMBL1060151	Percentage NEK7 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	116.0	CHEMBL4849	Homo sapiens	Activity	%	116.0
	2903353	CHEMBL1061980	Percentage NEK7 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	103.0	CHEMBL4849	Homo sapiens	Activity	%	103.0
	2903354	CHEMBL1061980	Percentage NEK7 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	102.0	CHEMBL4849	Homo sapiens	Activity	%	102.0
	2903355	CHEMBL1061981	Percentage NEK7 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	85.0	CHEMBL4849	Homo sapiens	Activity	%	85.0
	2903356	CHEMBL1063765	Percentage NEK7 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	92.0	CHEMBL4849	Homo sapiens	Activity	%	92.0
	2921241	CHEMBL1048297	Inhibition of NEK7 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	88.0	CHEMBL4849	Homo sapiens	Activity	%	88.0
	2924861	CHEMBL1057611	Inhibition of NEK7 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	92.0	CHEMBL4849	Homo sapiens	Activity	%	92.0
	2924862	CHEMBL1057611	Inhibition of NEK7 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	96.0	CHEMBL4849	Homo sapiens	Activity	%	96.0
	2924863	CHEMBL1057611	Inhibition of NEK7 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	95.0	CHEMBL4849	Homo sapiens	Activity	%	95.0
	2924864	CHEMBL1057611	Inhibition of NEK7 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	89.0	CHEMBL4849	Homo sapiens	Activity	%	89.0
	2999032	CHEMBL1043735	Inhibition of NEK7 assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	104.0	CHEMBL4849	Homo sapiens	Activity	%	104.0
	2999822	CHEMBL1043735	Inhibition of NEK7 assessed as residual activity at 10 uM by Cherenkov counting relative to control	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	3052421	CHEMBL1069802	Residual activity of NEK7 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	97.0	CHEMBL4849	Homo sapiens	Residual activity	%	97.0
	3052673	CHEMBL1041160	Residual activity of NEK7 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	103.0	CHEMBL4849	Homo sapiens	Residual activity	%	103.0
	3053982	CHEMBL1050313	Residual activity of NEK7 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	239.0	CHEMBL4849	Homo sapiens	Residual activity	%	239.0
	3054234	CHEMBL1069802	Residual activity of NEK7 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	83.0	CHEMBL4849	Homo sapiens	Residual activity	%	83.0
	3055521	CHEMBL1041160	Residual activity of NEK7 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	95.0	CHEMBL4849	Homo sapiens	Residual activity	%	95.0
	3056826	CHEMBL1050313	Residual activity of NEK7 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	254.0	CHEMBL4849	Homo sapiens	Residual activity	%	254.0
	3057078	CHEMBL1069802	Residual activity of NEK7 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	95.0	CHEMBL4849	Homo sapiens	Residual activity	%	95.0
	3058398	CHEMBL1041160	Residual activity of NEK7 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	104.0	CHEMBL4849	Homo sapiens	Residual activity	%	104.0
	3059682	CHEMBL1050313	Residual activity of NEK7 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	224.0	CHEMBL4849	Homo sapiens	Residual activity	%	224.0
	3130792	CHEMBL1065101	Inhibition of NEK7 at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	3131771	CHEMBL1065775	Inhibition of NEK7 at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	3213986	CHEMBL1116734	Inhibition of NEK7 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-1.0	CHEMBL4849	Homo sapiens	INH	%	-1.0
	3224899	CHEMBL1100977	Inhibition of NEK7 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	3226278	CHEMBL1100977	Inhibition of NEK7 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	3306944	CHEMBL1118068	Inhibition of NEK7 at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	90.0	CHEMBL4849	Homo sapiens	INH	%	90.0
	3332056	CHEMBL1166594	Inhibition of NEK7 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	3333471	CHEMBL1166594	Inhibition of NEK7 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	3334876	CHEMBL1166594	Inhibition of NEK7 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	3336296	CHEMBL1166594	Inhibition of NEK7 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	3341838	CHEMBL1166594	Inhibition of NEK7 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	3343285	CHEMBL1166594	Inhibition of NEK7 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	3358704	CHEMBL1174946	Inhibition of NEK7 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	88.0	CHEMBL4849	Homo sapiens	INH	%	88.0
	3359146	CHEMBL1174946	Inhibition of NEK7 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	3443465	CHEMBL1244231	Inhibition of NEK7 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	2.0	CHEMBL4849	Homo sapiens	INH	%	2.0
	3443682	CHEMBL1244231	Inhibition of NEK7 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	0.0	CHEMBL4849	Homo sapiens	INH	%	0.0
	3444837	CHEMBL1244231	Inhibition of NEK7 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	2.0	CHEMBL4849	Homo sapiens	INH	%	2.0
	3445223	CHEMBL1244540	Binding affinity to NEK7	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	4000.0	CHEMBL4849	Homo sapiens	Kd	nM	4000.0
	3445461	CHEMBL1244231	Inhibition of NEK7 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	1.0	CHEMBL4849	Homo sapiens	INH	%	1.0
	3445678	CHEMBL1244231	Inhibition of NEK7 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	8.0	CHEMBL4849	Homo sapiens	INH	%	8.0
	3448532	CHEMBL1244540	Binding affinity to NEK7	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	3449470	CHEMBL1244540	Binding affinity to NEK7	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	4100.0	CHEMBL4849	Homo sapiens	Kd	nM	4100.0
	3449762	CHEMBL1244540	Binding affinity to NEK7	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	3450165	CHEMBL1244540	Binding affinity to NEK7	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	3450821	CHEMBL1244540	Binding affinity to NEK7	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	3451080	CHEMBL1244540	Binding affinity to NEK7	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	uM	10.0
	3463299	CHEMBL1252601	Inhibition of NEK7 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	1.0	CHEMBL4849	Homo sapiens	INH	%	1.0
	3463843	CHEMBL1252601	Inhibition of NEK7 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	13.0	CHEMBL4849	Homo sapiens	INH	%	13.0
	3464062	CHEMBL1252601	Inhibition of NEK7 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	9.0	CHEMBL4849	Homo sapiens	INH	%	9.0
	5121125	CHEMBL1646217	Inhibition of human NEK7 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	112.0	CHEMBL4849	Homo sapiens	INH	%	112.0
	6341098	CHEMBL1826024	Activity of NEK7 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	6385653	CHEMBL1838130	Inhibition of human NEK7 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	6385654	CHEMBL1838130	Inhibition of human NEK7 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	6385655	CHEMBL1838130	Inhibition of human NEK7 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	6385656	CHEMBL1838130	Inhibition of human NEK7 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	6385657	CHEMBL1838130	Inhibition of human NEK7 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	7567116	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7567575	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7568046	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7568514	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7568946	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	3200.0	CHEMBL4849	Homo sapiens	Kd	nM	3200.0
	7569089	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7569549	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7570021	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7570484	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7570911	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	4100.0	CHEMBL4849	Homo sapiens	Kd	nM	4100.0
	7571065	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7571522	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	5700.0	CHEMBL4849	Homo sapiens	Kd	nM	5700.0
	7571998	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	4900.0	CHEMBL4849	Homo sapiens	Kd	nM	4900.0
	7573046	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	6100.0	CHEMBL4849	Homo sapiens	Kd	nM	6100.0
	7573503	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7573979	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7574006	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7574414	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	2300.0	CHEMBL4849	Homo sapiens	Kd	nM	2300.0
	7575024	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7575485	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7575979	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7576387	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7576998	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7577493	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7577963	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7578368	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	160.0	CHEMBL4849	Homo sapiens	Kd	nM	160.0
	7579388	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7579862	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	210.0	CHEMBL4849	Homo sapiens	Kd	nM	210.0
	7580331	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7580734	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7580922	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7581307	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7581752	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7582223	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7582687	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7583087	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	8700.0	CHEMBL4849	Homo sapiens	Kd	nM	8700.0
	7583268	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7583665	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7584110	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7584581	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7585043	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	11.0	CHEMBL4849	Homo sapiens	Kd	nM	11.0
	7585447	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7585598	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7586006	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7586452	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7586923	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7587377	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7587559	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7587978	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7588431	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7588902	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7589524	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7589948	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	4000.0	CHEMBL4849	Homo sapiens	Kd	nM	4000.0
	7590415	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7590898	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7591497	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7591919	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	5600.0	CHEMBL4849	Homo sapiens	Kd	nM	5600.0
	7592422	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7592875	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7593464	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7593899	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7593929	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7594402	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7594854	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7595432	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7595908	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7596379	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7596826	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7597415	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7597888	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7598358	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
	7598800	CHEMBL1908451	Binding constant for NEK7 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	4500.0	CHEMBL4849	Homo sapiens	Kd	nM	4500.0
	8003596	CHEMBL1942754	Inhibition of human NEK7 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	8003597	CHEMBL1942754	Inhibition of human NEK7 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	8003598	CHEMBL1942754	Inhibition of human NEK7 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	8003599	CHEMBL1942754	Inhibition of human NEK7 in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	8061327	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.75	CHEMBL4849	Homo sapiens	Inhibition	%	1.75
	8061504	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.54	CHEMBL4849	Homo sapiens	Inhibition	%	-2.54
	8061835	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.65	CHEMBL4849	Homo sapiens	Inhibition	%	2.65
	8062026	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.8	CHEMBL4849	Homo sapiens	Inhibition	%	3.8
	8062366	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.76	CHEMBL4849	Homo sapiens	Inhibition	%	3.76
	8062528	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	10.04	CHEMBL4849	Homo sapiens	Inhibition	%	10.04
	8062752	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.44	CHEMBL4849	Homo sapiens	Inhibition	%	5.44
	8062850	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.01	CHEMBL4849	Homo sapiens	Inhibition	%	2.01
	8063206	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.7	CHEMBL4849	Homo sapiens	Inhibition	%	1.7
	8063373	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.34	CHEMBL4849	Homo sapiens	Inhibition	%	3.34
	8063705	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.26	CHEMBL4849	Homo sapiens	Inhibition	%	2.26
	8063887	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	4.49	CHEMBL4849	Homo sapiens	Inhibition	%	4.49
	8064111	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.18	CHEMBL4849	Homo sapiens	Inhibition	%	4.18
	8064226	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.15	CHEMBL4849	Homo sapiens	Inhibition	%	3.15
	8064436	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.24	CHEMBL4849	Homo sapiens	Inhibition	%	3.24
	8064660	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.3	CHEMBL4849	Homo sapiens	Inhibition	%	2.3
	8064798	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.23	CHEMBL4849	Homo sapiens	Inhibition	%	1.23
	8064964	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.28	CHEMBL4849	Homo sapiens	Inhibition	%	3.28
	8065188	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.52	CHEMBL4849	Homo sapiens	Inhibition	%	2.52
	8065304	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.68	CHEMBL4849	Homo sapiens	Inhibition	%	1.68
	8065703	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.91	CHEMBL4849	Homo sapiens	Inhibition	%	2.91
	8065818	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.09	CHEMBL4849	Homo sapiens	Inhibition	%	3.09
	8066252	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.57	CHEMBL4849	Homo sapiens	Inhibition	%	2.57
	8066388	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.83	CHEMBL4849	Homo sapiens	Inhibition	%	0.83
	8066778	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.09	CHEMBL4849	Homo sapiens	Inhibition	%	1.09
	8066902	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.11	CHEMBL4849	Homo sapiens	Inhibition	%	3.11
	8067126	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.69	CHEMBL4849	Homo sapiens	Inhibition	%	2.69
	8067301	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.46	CHEMBL4849	Homo sapiens	Inhibition	%	2.46
	8067422	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.46	CHEMBL4849	Homo sapiens	Inhibition	%	1.46
	8067646	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	3.72	CHEMBL4849	Homo sapiens	Inhibition	%	3.72
	8067856	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.72	CHEMBL4849	Homo sapiens	Inhibition	%	1.72
	8067991	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.07	CHEMBL4849	Homo sapiens	Inhibition	%	2.07
	8068215	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.54	CHEMBL4849	Homo sapiens	Inhibition	%	3.54
	8068379	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.82	CHEMBL4849	Homo sapiens	Inhibition	%	2.82
	8068728	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.7	CHEMBL4849	Homo sapiens	Inhibition	%	2.7
	8068902	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.19	CHEMBL4849	Homo sapiens	Inhibition	%	2.19
	8069251	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.56	CHEMBL4849	Homo sapiens	Inhibition	%	2.56
	8069546	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.4	CHEMBL4849	Homo sapiens	Inhibition	%	2.4
	8069707	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.01	CHEMBL4849	Homo sapiens	Inhibition	%	1.01
	8070057	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	2.46	CHEMBL4849	Homo sapiens	Inhibition	%	2.46
	8070229	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.77	CHEMBL4849	Homo sapiens	Inhibition	%	2.77
	8070578	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.44	CHEMBL4849	Homo sapiens	Inhibition	%	2.44
	8070876	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	1.08	CHEMBL4849	Homo sapiens	Inhibition	%	1.08
	8071033	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.91	CHEMBL4849	Homo sapiens	Inhibition	%	1.91
	8071257	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.96	CHEMBL4849	Homo sapiens	Inhibition	%	1.96
	8071383	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.98	CHEMBL4849	Homo sapiens	Inhibition	%	2.98
	8071556	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.17	CHEMBL4849	Homo sapiens	Inhibition	%	2.17
	8071780	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.18	CHEMBL4849	Homo sapiens	Inhibition	%	4.18
	8071905	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.94	CHEMBL4849	Homo sapiens	Inhibition	%	0.94
	8072219	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.69	CHEMBL4849	Homo sapiens	Inhibition	%	2.69
	8072600	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.02	CHEMBL4849	Homo sapiens	Inhibition	%	2.02
	8072725	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.74	CHEMBL4849	Homo sapiens	Inhibition	%	1.74
	8073116	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.03	CHEMBL4849	Homo sapiens	Inhibition	%	3.03
	8073241	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.35	CHEMBL4849	Homo sapiens	Inhibition	%	1.35
	8073465	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.53	CHEMBL4849	Homo sapiens	Inhibition	%	0.53
	8073584	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.58	CHEMBL4849	Homo sapiens	Inhibition	%	2.58
	8073817	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.59	CHEMBL4849	Homo sapiens	Inhibition	%	1.59
	8074193	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.72	CHEMBL4849	Homo sapiens	Inhibition	%	1.72
	8074323	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.1	CHEMBL4849	Homo sapiens	Inhibition	%	2.1
	8074547	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.24	CHEMBL4849	Homo sapiens	Inhibition	%	0.24
	8074704	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.21	CHEMBL4849	Homo sapiens	Inhibition	%	3.21
	8075055	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.54	CHEMBL4849	Homo sapiens	Inhibition	%	1.54
	8075166	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.3	CHEMBL4849	Homo sapiens	Inhibition	%	2.3
	8075390	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.31	CHEMBL4849	Homo sapiens	Inhibition	%	2.31
	8075403	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	2.37	CHEMBL4849	Homo sapiens	Inhibition	%	2.37
	8075627	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.41	CHEMBL4849	Homo sapiens	Inhibition	%	0.41
	8075768	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.65	CHEMBL4849	Homo sapiens	Inhibition	%	2.65
	8076134	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.25	CHEMBL4849	Homo sapiens	Inhibition	%	1.25
	8076282	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.73	CHEMBL4849	Homo sapiens	Inhibition	%	2.73
	8076640	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.41	CHEMBL4849	Homo sapiens	Inhibition	%	-0.41
	8076966	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.74	CHEMBL4849	Homo sapiens	Inhibition	%	1.74
	8077213	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.12	CHEMBL4849	Homo sapiens	Inhibition	%	1.12
	8077341	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.25	CHEMBL4849	Homo sapiens	Inhibition	%	1.25
	8077565	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.44	CHEMBL4849	Homo sapiens	Inhibition	%	3.44
	8077716	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.51	CHEMBL4849	Homo sapiens	Inhibition	%	0.51
	8077859	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	3.01	CHEMBL4849	Homo sapiens	Inhibition	%	3.01
	8078083	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.45	CHEMBL4849	Homo sapiens	Inhibition	%	2.45
	8078222	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.59	CHEMBL4849	Homo sapiens	Inhibition	%	-0.59
	8078548	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.03	CHEMBL4849	Homo sapiens	Inhibition	%	2.03
	8078798	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.58	CHEMBL4849	Homo sapiens	Inhibition	%	0.58
	8079138	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.07	CHEMBL4849	Homo sapiens	Inhibition	%	3.07
	8079296	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.63	CHEMBL4849	Homo sapiens	Inhibition	%	0.63
	8079662	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.33	CHEMBL4849	Homo sapiens	Inhibition	%	2.33
	8079801	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-3.23	CHEMBL4849	Homo sapiens	Inhibition	%	-3.23
	8080130	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.72	CHEMBL4849	Homo sapiens	Inhibition	%	0.72
	8080382	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.03	CHEMBL4849	Homo sapiens	Inhibition	%	0.03
	8080721	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.47	CHEMBL4849	Homo sapiens	Inhibition	%	2.47
	8080885	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.36	CHEMBL4849	Homo sapiens	Inhibition	%	0.36
	8081244	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.07	CHEMBL4849	Homo sapiens	Inhibition	%	2.07
	8081388	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	7.49	CHEMBL4849	Homo sapiens	Inhibition	%	7.49
	8081612	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	8.87	CHEMBL4849	Homo sapiens	Inhibition	%	8.87
	8081715	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.78	CHEMBL4849	Homo sapiens	Inhibition	%	1.78
	8081967	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.46	CHEMBL4849	Homo sapiens	Inhibition	%	0.46
	8082304	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.49	CHEMBL4849	Homo sapiens	Inhibition	%	2.49
	8082477	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.09	CHEMBL4849	Homo sapiens	Inhibition	%	-2.09
	8082701	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-4.78	CHEMBL4849	Homo sapiens	Inhibition	%	-4.78
	8082824	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.14	CHEMBL4849	Homo sapiens	Inhibition	%	3.14
	8083204	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	6.31	CHEMBL4849	Homo sapiens	Inhibition	%	6.31
	8083303	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.51	CHEMBL4849	Homo sapiens	Inhibition	%	1.51
	8083527	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.34	CHEMBL4849	Homo sapiens	Inhibition	%	2.34
	8083557	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.07	CHEMBL4849	Homo sapiens	Inhibition	%	0.07
	8083781	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.97	CHEMBL4849	Homo sapiens	Inhibition	%	-0.97
	8083891	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.21	CHEMBL4849	Homo sapiens	Inhibition	%	3.21
	8084300	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	4.59	CHEMBL4849	Homo sapiens	Inhibition	%	4.59
	8084418	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.04	CHEMBL4849	Homo sapiens	Inhibition	%	2.04
	8084642	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.52	CHEMBL4849	Homo sapiens	Inhibition	%	1.52
	8084803	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.01	CHEMBL4849	Homo sapiens	Inhibition	%	5.01
	8085125	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.08	CHEMBL4849	Homo sapiens	Inhibition	%	1.08
	8085381	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-6.27	CHEMBL4849	Homo sapiens	Inhibition	%	-6.27
	8085489	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.4	CHEMBL4849	Homo sapiens	Inhibition	%	3.4
	8085713	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.94	CHEMBL4849	Homo sapiens	Inhibition	%	2.94
	8085902	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	7.69	CHEMBL4849	Homo sapiens	Inhibition	%	7.69
	8086241	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.66	CHEMBL4849	Homo sapiens	Inhibition	%	1.66
	8086403	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	7.02	CHEMBL4849	Homo sapiens	Inhibition	%	7.02
	8086726	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.2	CHEMBL4849	Homo sapiens	Inhibition	%	3.2
	8086937	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	4.23	CHEMBL4849	Homo sapiens	Inhibition	%	4.23
	8087319	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.13	CHEMBL4849	Homo sapiens	Inhibition	%	3.13
	8087433	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	5.28	CHEMBL4849	Homo sapiens	Inhibition	%	5.28
	8087657	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.39	CHEMBL4849	Homo sapiens	Inhibition	%	2.39
	8087795	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.67	CHEMBL4849	Homo sapiens	Inhibition	%	5.67
	8088161	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	10.75	CHEMBL4849	Homo sapiens	Inhibition	%	10.75
	8088309	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.35	CHEMBL4849	Homo sapiens	Inhibition	%	1.35
	8088661	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.47	CHEMBL4849	Homo sapiens	Inhibition	%	3.47
	8088978	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.22	CHEMBL4849	Homo sapiens	Inhibition	%	4.22
	8089106	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-8.48	CHEMBL4849	Homo sapiens	Inhibition	%	-8.48
	8089478	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	-1.18	CHEMBL4849	Homo sapiens	Inhibition	%	-1.18
	8089598	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.78	CHEMBL4849	Homo sapiens	Inhibition	%	0.78
	8089822	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	-0.08	CHEMBL4849	Homo sapiens	Inhibition	%	-0.08
	8090002	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.7	CHEMBL4849	Homo sapiens	Inhibition	%	0.7
	8090167	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.3	CHEMBL4849	Homo sapiens	Inhibition	%	3.3
	8090391	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	6.3	CHEMBL4849	Homo sapiens	Inhibition	%	6.3
	8090558	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.2	CHEMBL4849	Homo sapiens	Inhibition	%	1.2
	8090697	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.03	CHEMBL4849	Homo sapiens	Inhibition	%	0.03
	8090921	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.37	CHEMBL4849	Homo sapiens	Inhibition	%	1.37
	8091126	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.47	CHEMBL4849	Homo sapiens	Inhibition	%	2.47
	8091263	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	9.84	CHEMBL4849	Homo sapiens	Inhibition	%	9.84
	8091487	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	4.64	CHEMBL4849	Homo sapiens	Inhibition	%	4.64
	8091642	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	8.32	CHEMBL4849	Homo sapiens	Inhibition	%	8.32
	8091982	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.45	CHEMBL4849	Homo sapiens	Inhibition	%	5.45
	8092119	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.34	CHEMBL4849	Homo sapiens	Inhibition	%	2.34
	8092494	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.02	CHEMBL4849	Homo sapiens	Inhibition	%	4.02
	8092642	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	6.39	CHEMBL4849	Homo sapiens	Inhibition	%	6.39
	8092866	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.09	CHEMBL4849	Homo sapiens	Inhibition	%	-0.09
	8092995	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.57	CHEMBL4849	Homo sapiens	Inhibition	%	4.57
	8093307	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.99	CHEMBL4849	Homo sapiens	Inhibition	%	2.99
	8093447	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.7	CHEMBL4849	Homo sapiens	Inhibition	%	1.7
	8093671	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.12	CHEMBL4849	Homo sapiens	Inhibition	%	0.12
	8093810	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	-0.48	CHEMBL4849	Homo sapiens	Inhibition	%	-0.48
	8094154	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.67	CHEMBL4849	Homo sapiens	Inhibition	%	2.67
	8094334	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl	Outside typical range	CHEMBL1909353	=	Inhibition	%	-14.96	CHEMBL4849	Homo sapiens	Inhibition	%	-14.96
	8094733	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.07	CHEMBL4849	Homo sapiens	Inhibition	%	2.07
	8094889	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.34	CHEMBL4849	Homo sapiens	Inhibition	%	2.34
	8095253	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-1.48	CHEMBL4849	Homo sapiens	Inhibition	%	-1.48
	8095456	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.65	CHEMBL4849	Homo sapiens	Inhibition	%	3.65
	8095821	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	14.04	CHEMBL4849	Homo sapiens	Inhibition	%	14.04
	8095969	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.26	CHEMBL4849	Homo sapiens	Inhibition	%	0.26
	8096310	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.96	CHEMBL4849	Homo sapiens	Inhibition	%	3.96
	8096449	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	6.68	CHEMBL4849	Homo sapiens	Inhibition	%	6.68
	8096673	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.32	CHEMBL4849	Homo sapiens	Inhibition	%	1.32
	8096829	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	8.5	CHEMBL4849	Homo sapiens	Inhibition	%	8.5
	8097200	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	5.03	CHEMBL4849	Homo sapiens	Inhibition	%	5.03
	8097287	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	6.32	CHEMBL4849	Homo sapiens	Inhibition	%	6.32
	8097507	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-4.27	CHEMBL4849	Homo sapiens	Inhibition	%	-4.27
	8097881	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.33	CHEMBL4849	Homo sapiens	Inhibition	%	-0.33
	8098014	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.43	CHEMBL4849	Homo sapiens	Inhibition	%	-2.43
	8098358	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.3	CHEMBL4849	Homo sapiens	Inhibition	%	0.3
	8098538	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.89	CHEMBL4849	Homo sapiens	Inhibition	%	0.89
	8098762	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.99	CHEMBL4849	Homo sapiens	Inhibition	%	-0.99
	8098947	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	7.1	CHEMBL4849	Homo sapiens	Inhibition	%	7.1
	8099091	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.37	CHEMBL4849	Homo sapiens	Inhibition	%	2.37
	8099315	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.98	CHEMBL4849	Homo sapiens	Inhibition	%	3.98
	8099457	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.7	CHEMBL4849	Homo sapiens	Inhibition	%	1.7
	8099651	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.73	CHEMBL4849	Homo sapiens	Inhibition	%	1.73
	8100022	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	4.05	CHEMBL4849	Homo sapiens	Inhibition	%	4.05
	8100168	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	6.18	CHEMBL4849	Homo sapiens	Inhibition	%	6.18
	8100392	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.6	CHEMBL4849	Homo sapiens	Inhibition	%	2.6
	8100508	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	6.62	CHEMBL4849	Homo sapiens	Inhibition	%	6.62
	8100872	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	5.75	CHEMBL4849	Homo sapiens	Inhibition	%	5.75
	8101032	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.68	CHEMBL4849	Homo sapiens	Inhibition	%	3.68
	8101398	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-3.32	CHEMBL4849	Homo sapiens	Inhibition	%	-3.32
	8101583	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.12	CHEMBL4849	Homo sapiens	Inhibition	%	3.12
	8101836	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.88	CHEMBL4849	Homo sapiens	Inhibition	%	2.88
	8102215	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.67	CHEMBL4849	Homo sapiens	Inhibition	%	-1.67
	8102346	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-0.18	CHEMBL4849	Homo sapiens	Inhibition	%	-0.18
	8102570	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.6	CHEMBL4849	Homo sapiens	Inhibition	%	-0.6
	8102690	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.66	CHEMBL4849	Homo sapiens	Inhibition	%	0.66
	8103092	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.84	CHEMBL4849	Homo sapiens	Inhibition	%	1.84
	8103288	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.87	CHEMBL4849	Homo sapiens	Inhibition	%	1.87
	8103650	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	2.07	CHEMBL4849	Homo sapiens	Inhibition	%	2.07
	8103800	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC	Outside typical range	CHEMBL471789	=	Inhibition	%	-27.35	CHEMBL4849	Homo sapiens	Inhibition	%	-27.35
	8103985	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.38	CHEMBL4849	Homo sapiens	Inhibition	%	2.38
	8104209	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.46	CHEMBL4849	Homo sapiens	Inhibition	%	1.46
	8104357	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	10.13	CHEMBL4849	Homo sapiens	Inhibition	%	10.13
	8104727	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	8.73	CHEMBL4849	Homo sapiens	Inhibition	%	8.73
	8104841	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.62	CHEMBL4849	Homo sapiens	Inhibition	%	3.62
	8105065	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	6.16	CHEMBL4849	Homo sapiens	Inhibition	%	6.16
	8105205	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.19	CHEMBL4849	Homo sapiens	Inhibition	%	-0.19
	8105371	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	8.72	CHEMBL4849	Homo sapiens	Inhibition	%	8.72
	8105595	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.24	CHEMBL4849	Homo sapiens	Inhibition	%	3.24
	8105733	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	3.67	CHEMBL4849	Homo sapiens	Inhibition	%	3.67
	8106013	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.97	CHEMBL4849	Homo sapiens	Inhibition	%	2.97
	8106178	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.62	CHEMBL4849	Homo sapiens	Inhibition	%	3.62
	8106402	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.85	CHEMBL4849	Homo sapiens	Inhibition	%	2.85
	8106558	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-3.47	CHEMBL4849	Homo sapiens	Inhibition	%	-3.47
	8106911	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	-0.03	CHEMBL4849	Homo sapiens	Inhibition	%	-0.03
	8107032	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-1.04	CHEMBL4849	Homo sapiens	Inhibition	%	-1.04
	8107256	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-5.21	CHEMBL4849	Homo sapiens	Inhibition	%	-5.21
	8107428	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-3.9	CHEMBL4849	Homo sapiens	Inhibition	%	-3.9
	8107629	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.72	CHEMBL4849	Homo sapiens	Inhibition	%	3.72
	8107988	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.47	CHEMBL4849	Homo sapiens	Inhibition	%	1.47
	8108146	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.64	CHEMBL4849	Homo sapiens	Inhibition	%	1.64
	8108545	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.97	CHEMBL4849	Homo sapiens	Inhibition	%	1.97
	8108692	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	4.32	CHEMBL4849	Homo sapiens	Inhibition	%	4.32
	8109058	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.66	CHEMBL4849	Homo sapiens	Inhibition	%	1.66
	8109396	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.84	CHEMBL4849	Homo sapiens	Inhibition	%	2.84
	8109526	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	4.4	CHEMBL4849	Homo sapiens	Inhibition	%	4.4
	8109921	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	8.62	CHEMBL4849	Homo sapiens	Inhibition	%	8.62
	8110053	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.14	CHEMBL4849	Homo sapiens	Inhibition	%	3.14
	8110332	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.6	CHEMBL4849	Homo sapiens	Inhibition	%	2.6
	8110722	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.37	CHEMBL4849	Homo sapiens	Inhibition	%	1.37
	8110880	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-5.43	CHEMBL4849	Homo sapiens	Inhibition	%	-5.43
	8111227	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-1.37	CHEMBL4849	Homo sapiens	Inhibition	%	-1.37
	8111578	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.99	CHEMBL4849	Homo sapiens	Inhibition	%	-0.99
	8111744	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.69	CHEMBL4849	Homo sapiens	Inhibition	%	3.69
	8111949	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.47	CHEMBL4849	Homo sapiens	Inhibition	%	2.47
	8112173	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.58	CHEMBL4849	Homo sapiens	Inhibition	%	4.58
	8112310	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.76	CHEMBL4849	Homo sapiens	Inhibition	%	0.76
	8112478	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-2.15	CHEMBL4849	Homo sapiens	Inhibition	%	-2.15
	8112702	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.41	CHEMBL4849	Homo sapiens	Inhibition	%	3.41
	8112874	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.9	CHEMBL4849	Homo sapiens	Inhibition	%	0.9
	8113026	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	9.78	CHEMBL4849	Homo sapiens	Inhibition	%	9.78
	8113250	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.06	CHEMBL4849	Homo sapiens	Inhibition	%	4.06
	8113386	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	5.83	CHEMBL4849	Homo sapiens	Inhibition	%	5.83
	8113734	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.48	CHEMBL4849	Homo sapiens	Inhibition	%	5.48
	8113850	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-2.98	CHEMBL4849	Homo sapiens	Inhibition	%	-2.98
	8114074	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.8	CHEMBL4849	Homo sapiens	Inhibition	%	1.8
	8114250	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.96	CHEMBL4849	Homo sapiens	Inhibition	%	2.96
	8114382	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.01	CHEMBL4849	Homo sapiens	Inhibition	%	5.01
	8114606	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.72	CHEMBL4849	Homo sapiens	Inhibition	%	2.72
	8114658	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.39	CHEMBL4849	Homo sapiens	Inhibition	%	4.39
	8114882	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.76	CHEMBL4849	Homo sapiens	Inhibition	%	3.76
	8115048	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.87	CHEMBL4849	Homo sapiens	Inhibition	%	2.87
	8115213	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-9.67	CHEMBL4849	Homo sapiens	Inhibition	%	-9.67
	8115437	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-4.17	CHEMBL4849	Homo sapiens	Inhibition	%	-4.17
	8115557	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-2.89	CHEMBL4849	Homo sapiens	Inhibition	%	-2.89
	8115914	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.58	CHEMBL4849	Homo sapiens	Inhibition	%	-0.58
	8116073	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-1.3	CHEMBL4849	Homo sapiens	Inhibition	%	-1.3
	8116500	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	-3.88	CHEMBL4849	Homo sapiens	Inhibition	%	-3.88
	8116634	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.39	CHEMBL4849	Homo sapiens	Inhibition	%	2.39
	8117030	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-0.15	CHEMBL4849	Homo sapiens	Inhibition	%	-0.15
	8117201	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.09	CHEMBL4849	Homo sapiens	Inhibition	%	1.09
	8117583	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	9.15	CHEMBL4849	Homo sapiens	Inhibition	%	9.15
	8117713	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.02	CHEMBL4849	Homo sapiens	Inhibition	%	0.02
	8117937	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.5	CHEMBL4849	Homo sapiens	Inhibition	%	2.5
	8118075	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	3.19	CHEMBL4849	Homo sapiens	Inhibition	%	3.19
	8118415	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.31	CHEMBL4849	Homo sapiens	Inhibition	%	4.31
	8118587	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	7.52	CHEMBL4849	Homo sapiens	Inhibition	%	7.52
	8118947	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.26	CHEMBL4849	Homo sapiens	Inhibition	%	4.26
	8119218	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	4.83	CHEMBL4849	Homo sapiens	Inhibition	%	4.83
	8119377	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-8.19	CHEMBL4849	Homo sapiens	Inhibition	%	-8.19
	8119768	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-3.8	CHEMBL4849	Homo sapiens	Inhibition	%	-3.8
	8119887	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-1.48	CHEMBL4849	Homo sapiens	Inhibition	%	-1.48
	8120111	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.7	CHEMBL4849	Homo sapiens	Inhibition	%	1.7
	8120250	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.01	CHEMBL4849	Homo sapiens	Inhibition	%	-0.01
	8120410	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	2.36	CHEMBL4849	Homo sapiens	Inhibition	%	2.36
	8120634	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.22	CHEMBL4849	Homo sapiens	Inhibition	%	-1.22
	8120835	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	5.15	CHEMBL4849	Homo sapiens	Inhibition	%	5.15
	8120963	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.24	CHEMBL4849	Homo sapiens	Inhibition	%	-0.24
	8121187	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.29	CHEMBL4849	Homo sapiens	Inhibition	%	1.29
	8121359	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.18	CHEMBL4849	Homo sapiens	Inhibition	%	2.18
	8121526	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.71	CHEMBL4849	Homo sapiens	Inhibition	%	0.71
	8121750	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.86	CHEMBL4849	Homo sapiens	Inhibition	%	0.86
	8121913	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.33	CHEMBL4849	Homo sapiens	Inhibition	%	3.33
	8122258	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-5.06	CHEMBL4849	Homo sapiens	Inhibition	%	-5.06
	8122396	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	6.72	CHEMBL4849	Homo sapiens	Inhibition	%	6.72
	8122740	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	10.43	CHEMBL4849	Homo sapiens	Inhibition	%	10.43
	8122907	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.2	CHEMBL4849	Homo sapiens	Inhibition	%	3.2
	8123131	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	7.72	CHEMBL4849	Homo sapiens	Inhibition	%	7.72
	8123273	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.29	CHEMBL4849	Homo sapiens	Inhibition	%	3.29
	8123551	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	9.65	CHEMBL4849	Homo sapiens	Inhibition	%	9.65
	8123701	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.01	CHEMBL4849	Homo sapiens	Inhibition	%	3.01
	8123925	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	5.26	CHEMBL4849	Homo sapiens	Inhibition	%	5.26
	8124092	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.81	CHEMBL4849	Homo sapiens	Inhibition	%	-0.81
	8124435	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-0.48	CHEMBL4849	Homo sapiens	Inhibition	%	-0.48
	8124574	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.0	CHEMBL4849	Homo sapiens	Inhibition	%	0.0
	8124963	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.45	CHEMBL4849	Homo sapiens	Inhibition	%	1.45
	8125164	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.65	CHEMBL4849	Homo sapiens	Inhibition	%	2.65
	8125518	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.09	CHEMBL4849	Homo sapiens	Inhibition	%	0.09
	8125686	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.21	CHEMBL4849	Homo sapiens	Inhibition	%	2.21
	8126074	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.06	CHEMBL4849	Homo sapiens	Inhibition	%	-0.06
	8126238	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	9.69	CHEMBL4849	Homo sapiens	Inhibition	%	9.69
	8126577	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-5.1	CHEMBL4849	Homo sapiens	Inhibition	%	-5.1
	8126713	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	1.21	CHEMBL4849	Homo sapiens	Inhibition	%	1.21
	8126937	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	7.53	CHEMBL4849	Homo sapiens	Inhibition	%	7.53
	8127059	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.94	CHEMBL4849	Homo sapiens	Inhibition	%	3.94
	8127450	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.07	CHEMBL4849	Homo sapiens	Inhibition	%	4.07
	8127592	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	5.2	CHEMBL4849	Homo sapiens	Inhibition	%	5.2
	8127880	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.1	CHEMBL4849	Homo sapiens	Inhibition	%	4.1
	8128256	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.87	CHEMBL4849	Homo sapiens	Inhibition	%	3.87
	8128423	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.76	CHEMBL4849	Homo sapiens	Inhibition	%	-2.76
	8128766	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.19	CHEMBL4849	Homo sapiens	Inhibition	%	4.19
	8128903	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.57	CHEMBL4849	Homo sapiens	Inhibition	%	0.57
	8129127	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.43	CHEMBL4849	Homo sapiens	Inhibition	%	0.43
	8129298	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-2.05	CHEMBL4849	Homo sapiens	Inhibition	%	-2.05
	8129487	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	5.98	CHEMBL4849	Homo sapiens	Inhibition	%	5.98
	8129850	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.6	CHEMBL4849	Homo sapiens	Inhibition	%	1.6
	8130011	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-1.64	CHEMBL4849	Homo sapiens	Inhibition	%	-1.64
	8130235	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.79	CHEMBL4849	Homo sapiens	Inhibition	%	1.79
	8130407	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.15	CHEMBL4849	Homo sapiens	Inhibition	%	-1.15
	8130567	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.37	CHEMBL4849	Homo sapiens	Inhibition	%	3.37
	8130907	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.74	CHEMBL4849	Homo sapiens	Inhibition	%	3.74
	8131270	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.35	CHEMBL4849	Homo sapiens	Inhibition	%	3.35
	8131390	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	9.34	CHEMBL4849	Homo sapiens	Inhibition	%	9.34
	8131614	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	4.05	CHEMBL4849	Homo sapiens	Inhibition	%	4.05
	8131781	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	0.27	CHEMBL4849	Homo sapiens	Inhibition	%	0.27
	8131922	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.42	CHEMBL4849	Homo sapiens	Inhibition	%	2.42
	8132146	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	-0.46	CHEMBL4849	Homo sapiens	Inhibition	%	-0.46
	8132208	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.98	CHEMBL4849	Homo sapiens	Inhibition	%	1.98
	8132432	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.13	CHEMBL4849	Homo sapiens	Inhibition	%	3.13
	8132579	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.65	CHEMBL4849	Homo sapiens	Inhibition	%	4.65
	8132747	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-1.23	CHEMBL4849	Homo sapiens	Inhibition	%	-1.23
	8132971	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-1.28	CHEMBL4849	Homo sapiens	Inhibition	%	-1.28
	8133092	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-2.2	CHEMBL4849	Homo sapiens	Inhibition	%	-2.2
	8133454	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.55	CHEMBL4849	Homo sapiens	Inhibition	%	2.55
	8133626	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.51	CHEMBL4849	Homo sapiens	Inhibition	%	0.51
	8133806	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.05	CHEMBL4849	Homo sapiens	Inhibition	%	2.05
	8134030	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	5.08	CHEMBL4849	Homo sapiens	Inhibition	%	5.08
	8134178	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-2.18	CHEMBL4849	Homo sapiens	Inhibition	%	-2.18
	8134562	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.66	CHEMBL4849	Homo sapiens	Inhibition	%	0.66
	8134746	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-4.38	CHEMBL4849	Homo sapiens	Inhibition	%	-4.38
	8134906	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	9.4	CHEMBL4849	Homo sapiens	Inhibition	%	9.4
	8135130	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	2.68	CHEMBL4849	Homo sapiens	Inhibition	%	2.68
	8135245	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	5.22	CHEMBL4849	Homo sapiens	Inhibition	%	5.22
	8135610	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	7.05	CHEMBL4849	Homo sapiens	Inhibition	%	7.05
	8135955	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	9.66	CHEMBL4849	Homo sapiens	Inhibition	%	9.66
	8136123	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.9	CHEMBL4849	Homo sapiens	Inhibition	%	3.9
	8136491	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.69	CHEMBL4849	Homo sapiens	Inhibition	%	2.69
	8136781	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.22	CHEMBL4849	Homo sapiens	Inhibition	%	2.22
	8136916	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.34	CHEMBL4849	Homo sapiens	Inhibition	%	2.34
	8137303	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-1.02	CHEMBL4849	Homo sapiens	Inhibition	%	-1.02
	8137423	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.48	CHEMBL4849	Homo sapiens	Inhibition	%	0.48
	8137647	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.37	CHEMBL4849	Homo sapiens	Inhibition	%	-1.37
	8137795	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.27	CHEMBL4849	Homo sapiens	Inhibition	%	1.27
	8137961	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.18	CHEMBL4849	Homo sapiens	Inhibition	%	-2.18
	8138185	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.08	CHEMBL4849	Homo sapiens	Inhibition	%	0.08
	8138364	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.6	CHEMBL4849	Homo sapiens	Inhibition	%	1.6
	8138512	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.87	CHEMBL4849	Homo sapiens	Inhibition	%	-0.87
	8138736	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-6.3	CHEMBL4849	Homo sapiens	Inhibition	%	-6.3
	8138894	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.16	CHEMBL4849	Homo sapiens	Inhibition	%	1.16
	8139079	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-3.48	CHEMBL4849	Homo sapiens	Inhibition	%	-3.48
	8139462	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	7.82	CHEMBL4849	Homo sapiens	Inhibition	%	7.82
	8139576	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.28	CHEMBL4849	Homo sapiens	Inhibition	%	2.28
	8139800	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.17	CHEMBL4849	Homo sapiens	Inhibition	%	4.17
	8139941	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.99	CHEMBL4849	Homo sapiens	Inhibition	%	2.99
	8140288	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.27	CHEMBL4849	Homo sapiens	Inhibition	%	3.27
	8140447	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	8.57	CHEMBL4849	Homo sapiens	Inhibition	%	8.57
	8140814	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.77	CHEMBL4849	Homo sapiens	Inhibition	%	4.77
	8141116	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.4	CHEMBL4849	Homo sapiens	Inhibition	%	3.4
	8141246	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.79	CHEMBL4849	Homo sapiens	Inhibition	%	3.79
	8141470	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.23	CHEMBL4849	Homo sapiens	Inhibition	%	2.23
	8141630	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	-0.91	CHEMBL4849	Homo sapiens	Inhibition	%	-0.91
	8141973	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.6	CHEMBL4849	Homo sapiens	Inhibition	%	0.6
	8142134	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.18	CHEMBL4849	Homo sapiens	Inhibition	%	2.18
	8142526	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-2.74	CHEMBL4849	Homo sapiens	Inhibition	%	-2.74
	8142702	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.52	CHEMBL4849	Homo sapiens	Inhibition	%	5.52
	8143075	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-4.59	CHEMBL4849	Homo sapiens	Inhibition	%	-4.59
	8143230	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.31	CHEMBL4849	Homo sapiens	Inhibition	%	1.31
	8143417	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.66	CHEMBL4849	Homo sapiens	Inhibition	%	4.66
	8143641	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	10.58	CHEMBL4849	Homo sapiens	Inhibition	%	10.58
	8143800	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.74	CHEMBL4849	Homo sapiens	Inhibition	%	0.74
	8144138	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	3.08	CHEMBL4849	Homo sapiens	Inhibition	%	3.08
	8144277	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	8.43	CHEMBL4849	Homo sapiens	Inhibition	%	8.43
	8144501	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.54	CHEMBL4849	Homo sapiens	Inhibition	%	3.54
	8144631	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	9.14	CHEMBL4849	Homo sapiens	Inhibition	%	9.14
	8144784	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.41	CHEMBL4849	Homo sapiens	Inhibition	%	3.41
	8145008	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	7.48	CHEMBL4849	Homo sapiens	Inhibition	%	7.48
	8145145	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.88	CHEMBL4849	Homo sapiens	Inhibition	%	3.88
	8145458	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.29	CHEMBL4849	Homo sapiens	Inhibition	%	3.29
	8145806	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.61	CHEMBL4849	Homo sapiens	Inhibition	%	2.61
	8145967	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.01	CHEMBL4849	Homo sapiens	Inhibition	%	1.01
	8146311	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.35	CHEMBL4849	Homo sapiens	Inhibition	%	-0.35
	8146471	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.38	CHEMBL4849	Homo sapiens	Inhibition	%	1.38
	8146862	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.71	CHEMBL4849	Homo sapiens	Inhibition	%	-0.71
	8147031	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.88	CHEMBL4849	Homo sapiens	Inhibition	%	1.88
	8147397	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.4	CHEMBL4849	Homo sapiens	Inhibition	%	2.4
	8147550	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.32	CHEMBL4849	Homo sapiens	Inhibition	%	1.32
	8147774	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.12	CHEMBL4849	Homo sapiens	Inhibition	%	1.12
	8147961	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.31	CHEMBL4849	Homo sapiens	Inhibition	%	4.31
	8148119	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.29	CHEMBL4849	Homo sapiens	Inhibition	%	5.29
	8148457	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	5.42	CHEMBL4849	Homo sapiens	Inhibition	%	5.42
	8148820	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	6.77	CHEMBL4849	Homo sapiens	Inhibition	%	6.77
	8148958	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.46	CHEMBL4849	Homo sapiens	Inhibition	%	3.46
	8149341	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.49	CHEMBL4849	Homo sapiens	Inhibition	%	2.49
	8149475	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.26	CHEMBL4849	Homo sapiens	Inhibition	%	5.26
	8149699	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.5	CHEMBL4849	Homo sapiens	Inhibition	%	3.5
	8149797	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.46	CHEMBL4849	Homo sapiens	Inhibition	%	2.46
	8150146	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.83	CHEMBL4849	Homo sapiens	Inhibition	%	0.83
	8150306	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.59	CHEMBL4849	Homo sapiens	Inhibition	%	1.59
	8150530	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.01	CHEMBL4849	Homo sapiens	Inhibition	%	0.01
	8150650	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-3.05	CHEMBL4849	Homo sapiens	Inhibition	%	-3.05
	8150815	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.7	CHEMBL4849	Homo sapiens	Inhibition	%	1.7
	8151039	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	9.62	CHEMBL4849	Homo sapiens	Inhibition	%	9.62
	8151202	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-7.62	CHEMBL4849	Homo sapiens	Inhibition	%	-7.62
	8151379	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	8.97	CHEMBL4849	Homo sapiens	Inhibition	%	8.97
	8151603	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.99	CHEMBL4849	Homo sapiens	Inhibition	%	1.99
	8151741	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.88	CHEMBL4849	Homo sapiens	Inhibition	%	1.88
	8152119	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.05	CHEMBL4849	Homo sapiens	Inhibition	%	2.05
	8152307	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	8.9	CHEMBL4849	Homo sapiens	Inhibition	%	8.9
	8152465	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.1	CHEMBL4849	Homo sapiens	Inhibition	%	3.1
	8152689	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	9.54	CHEMBL4849	Homo sapiens	Inhibition	%	9.54
	8152803	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	2.57	CHEMBL4849	Homo sapiens	Inhibition	%	2.57
	8153166	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.08	CHEMBL4849	Homo sapiens	Inhibition	%	2.08
	8153303	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	9.69	CHEMBL4849	Homo sapiens	Inhibition	%	9.69
	8153527	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.41	CHEMBL4849	Homo sapiens	Inhibition	%	2.41
	8153684	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	7.27	CHEMBL4849	Homo sapiens	Inhibition	%	7.27
	8154041	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.72	CHEMBL4849	Homo sapiens	Inhibition	%	4.72
	8154138	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.99	CHEMBL4849	Homo sapiens	Inhibition	%	2.99
	8154362	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.9	CHEMBL4849	Homo sapiens	Inhibition	%	2.9
	8154488	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.99	CHEMBL4849	Homo sapiens	Inhibition	%	0.99
	8154871	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.48	CHEMBL4849	Homo sapiens	Inhibition	%	0.48
	8154991	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	-0.56	CHEMBL4849	Homo sapiens	Inhibition	%	-0.56
	8155391	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.44	CHEMBL4849	Homo sapiens	Inhibition	%	-1.44
	8155552	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-4.5	CHEMBL4849	Homo sapiens	Inhibition	%	-4.5
	8155954	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.9	CHEMBL4849	Homo sapiens	Inhibition	%	3.9
	8156092	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.88	CHEMBL4849	Homo sapiens	Inhibition	%	1.88
	8156304	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.35	CHEMBL4849	Homo sapiens	Inhibition	%	3.35
	8156528	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.17	CHEMBL4849	Homo sapiens	Inhibition	%	3.17
	8156678	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.24	CHEMBL4849	Homo sapiens	Inhibition	%	3.24
	8157045	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.65	CHEMBL4849	Homo sapiens	Inhibition	%	2.65
	8157165	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.34	CHEMBL4849	Homo sapiens	Inhibition	%	3.34
	8157389	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.74	CHEMBL4849	Homo sapiens	Inhibition	%	2.74
	8157530	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.91	CHEMBL4849	Homo sapiens	Inhibition	%	5.91
	8157884	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.48	CHEMBL4849	Homo sapiens	Inhibition	%	3.48
	8158045	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.75	CHEMBL4849	Homo sapiens	Inhibition	%	1.75
	8158295	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.57	CHEMBL4849	Homo sapiens	Inhibition	%	4.57
	8158677	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	4.61	CHEMBL4849	Homo sapiens	Inhibition	%	4.61
	8158846	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	6.28	CHEMBL4849	Homo sapiens	Inhibition	%	6.28
	8159205	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.68	CHEMBL4849	Homo sapiens	Inhibition	%	4.68
	8159549	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.63	CHEMBL4849	Homo sapiens	Inhibition	%	3.63
	8159680	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.88	CHEMBL4849	Homo sapiens	Inhibition	%	4.88
	8160045	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	3.16	CHEMBL4849	Homo sapiens	Inhibition	%	3.16
	8160182	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.96	CHEMBL4849	Homo sapiens	Inhibition	%	2.96
	8160556	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-2.24	CHEMBL4849	Homo sapiens	Inhibition	%	-2.24
	8160850	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.35	CHEMBL4849	Homo sapiens	Inhibition	%	3.35
	8161000	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.06	CHEMBL4849	Homo sapiens	Inhibition	%	3.06
	8161224	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.17	CHEMBL4849	Homo sapiens	Inhibition	%	3.17
	8161367	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.53	CHEMBL4849	Homo sapiens	Inhibition	%	3.53
	8161716	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.66	CHEMBL4849	Homo sapiens	Inhibition	%	4.66
	8161854	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	10.49	CHEMBL4849	Homo sapiens	Inhibition	%	10.49
	8162208	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.14	CHEMBL4849	Homo sapiens	Inhibition	%	4.14
	8162368	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	3.61	CHEMBL4849	Homo sapiens	Inhibition	%	3.61
	8162592	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.94	CHEMBL4849	Homo sapiens	Inhibition	%	0.94
	8162621	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.16	CHEMBL4849	Homo sapiens	Inhibition	%	6.16
	8162845	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	7.48	CHEMBL4849	Homo sapiens	Inhibition	%	7.48
	8162993	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	7.6	CHEMBL4849	Homo sapiens	Inhibition	%	7.6
	8163162	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.5	CHEMBL4849	Homo sapiens	Inhibition	%	3.5
	8163386	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.78	CHEMBL4849	Homo sapiens	Inhibition	%	5.78
	8163520	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.68	CHEMBL4849	Homo sapiens	Inhibition	%	3.68
	8163867	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.47	CHEMBL4849	Homo sapiens	Inhibition	%	2.47
	8164001	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	6.42	CHEMBL4849	Homo sapiens	Inhibition	%	6.42
	8164225	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	7.03	CHEMBL4849	Homo sapiens	Inhibition	%	7.03
	8164365	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	3.74	CHEMBL4849	Homo sapiens	Inhibition	%	3.74
	8164520	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.61	CHEMBL4849	Homo sapiens	Inhibition	%	3.61
	8164744	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	-4.91	CHEMBL4849	Homo sapiens	Inhibition	%	-4.91
	8164888	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-4.78	CHEMBL4849	Homo sapiens	Inhibition	%	-4.78
	8165182	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.53	CHEMBL4849	Homo sapiens	Inhibition	%	3.53
	8165547	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	4.4	CHEMBL4849	Homo sapiens	Inhibition	%	4.4
	8165690	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	6.49	CHEMBL4849	Homo sapiens	Inhibition	%	6.49
	8166040	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.35	CHEMBL4849	Homo sapiens	Inhibition	%	2.35
	8166178	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.33	CHEMBL4849	Homo sapiens	Inhibition	%	4.33
	8166402	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.76	CHEMBL4849	Homo sapiens	Inhibition	%	4.76
	8166532	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.5	CHEMBL4849	Homo sapiens	Inhibition	%	4.5
	8166857	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.17	CHEMBL4849	Homo sapiens	Inhibition	%	2.17
	8167169	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	6.06	CHEMBL4849	Homo sapiens	Inhibition	%	6.06
	8167310	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	13.86	CHEMBL4849	Homo sapiens	Inhibition	%	13.86
	8167698	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.68	CHEMBL4849	Homo sapiens	Inhibition	%	3.68
	8167831	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.72	CHEMBL4849	Homo sapiens	Inhibition	%	5.72
	8168055	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.91	CHEMBL4849	Homo sapiens	Inhibition	%	3.91
	8168179	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.54	CHEMBL4849	Homo sapiens	Inhibition	%	3.54
	8168544	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.38	CHEMBL4849	Homo sapiens	Inhibition	%	6.38
	8168680	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.39	CHEMBL4849	Homo sapiens	Inhibition	%	1.39
	8169068	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	4.18	CHEMBL4849	Homo sapiens	Inhibition	%	4.18
	8169210	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.35	CHEMBL4849	Homo sapiens	Inhibition	%	4.35
	8169514	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.42	CHEMBL4849	Homo sapiens	Inhibition	%	7.42
	8169872	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	-3.22	CHEMBL4849	Homo sapiens	Inhibition	%	-3.22
	8170017	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.34	CHEMBL4849	Homo sapiens	Inhibition	%	2.34
	8170241	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.46	CHEMBL4849	Homo sapiens	Inhibition	%	0.46
	8170366	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.43	CHEMBL4849	Homo sapiens	Inhibition	%	2.43
	8170730	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.99	CHEMBL4849	Homo sapiens	Inhibition	%	3.99
	8170865	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.32	CHEMBL4849	Homo sapiens	Inhibition	%	5.32
	8171286	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	3.64	CHEMBL4849	Homo sapiens	Inhibition	%	3.64
	8171503	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.89	CHEMBL4849	Homo sapiens	Inhibition	%	3.89
	8171644	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	12.72	CHEMBL4849	Homo sapiens	Inhibition	%	12.72
	8171868	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	42.07	CHEMBL4849	Homo sapiens	Inhibition	%	42.07
	8172021	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	4.53	CHEMBL4849	Homo sapiens	Inhibition	%	4.53
	8172377	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	6.08	CHEMBL4849	Homo sapiens	Inhibition	%	6.08
	8172505	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.72	CHEMBL4849	Homo sapiens	Inhibition	%	2.72
	8172871	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.14	CHEMBL4849	Homo sapiens	Inhibition	%	4.14
	8173007	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.22	CHEMBL4849	Homo sapiens	Inhibition	%	1.22
	8173231	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.64	CHEMBL4849	Homo sapiens	Inhibition	%	-2.64
	8173396	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.45	CHEMBL4849	Homo sapiens	Inhibition	%	2.45
	8173537	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.55	CHEMBL4849	Homo sapiens	Inhibition	%	2.55
	8173761	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.27	CHEMBL4849	Homo sapiens	Inhibition	%	5.27
	8173848	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	4.83	CHEMBL4849	Homo sapiens	Inhibition	%	4.83
	8174072	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	7.05	CHEMBL4849	Homo sapiens	Inhibition	%	7.05
	8174204	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.47	CHEMBL4849	Homo sapiens	Inhibition	%	2.47
	8174576	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.35	CHEMBL4849	Homo sapiens	Inhibition	%	3.35
	8174698	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.36	CHEMBL4849	Homo sapiens	Inhibition	%	2.36
	8175065	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.34	CHEMBL4849	Homo sapiens	Inhibition	%	3.34
	8175201	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.35	CHEMBL4849	Homo sapiens	Inhibition	%	3.35
	8175425	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.87	CHEMBL4849	Homo sapiens	Inhibition	%	4.87
	8175681	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.4	CHEMBL4849	Homo sapiens	Inhibition	%	4.4
	8175844	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	5.76	CHEMBL4849	Homo sapiens	Inhibition	%	5.76
	8176221	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.27	CHEMBL4849	Homo sapiens	Inhibition	%	7.27
	8176370	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.91	CHEMBL4849	Homo sapiens	Inhibition	%	2.91
	8176726	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	4.96	CHEMBL4849	Homo sapiens	Inhibition	%	4.96
	8176856	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.27	CHEMBL4849	Homo sapiens	Inhibition	%	2.27
	8177080	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.32	CHEMBL4849	Homo sapiens	Inhibition	%	2.32
	8177222	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.96	CHEMBL4849	Homo sapiens	Inhibition	%	4.96
	8177584	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	3.71	CHEMBL4849	Homo sapiens	Inhibition	%	3.71
	8177748	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.46	CHEMBL4849	Homo sapiens	Inhibition	%	3.46
	8178112	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.87	CHEMBL4849	Homo sapiens	Inhibition	%	4.87
	8178424	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.6	CHEMBL4849	Homo sapiens	Inhibition	%	3.6
	8178551	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.56	CHEMBL4849	Homo sapiens	Inhibition	%	1.56
	8178924	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.21	CHEMBL4849	Homo sapiens	Inhibition	%	3.21
	8179047	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.85	CHEMBL4849	Homo sapiens	Inhibition	%	3.85
	8179271	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.51	CHEMBL4849	Homo sapiens	Inhibition	%	3.51
	8179415	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.8	CHEMBL4849	Homo sapiens	Inhibition	%	3.8
	8179776	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.69	CHEMBL4849	Homo sapiens	Inhibition	%	3.69
	8180033	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	5.74	CHEMBL4849	Homo sapiens	Inhibition	%	5.74
	8180187	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.53	CHEMBL4849	Homo sapiens	Inhibition	%	3.53
	8180567	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	7.6	CHEMBL4849	Homo sapiens	Inhibition	%	7.6
	8180715	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	5.09	CHEMBL4849	Homo sapiens	Inhibition	%	5.09
	8180939	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.01	CHEMBL4849	Homo sapiens	Inhibition	%	3.01
	8181072	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	5.32	CHEMBL4849	Homo sapiens	Inhibition	%	5.32
	8181427	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21	Outside typical range	CHEMBL405042	=	Inhibition	%	-11.53	CHEMBL4849	Homo sapiens	Inhibition	%	-11.53
	8181567	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.04	CHEMBL4849	Homo sapiens	Inhibition	%	4.04
	8181930	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	5.28	CHEMBL4849	Homo sapiens	Inhibition	%	5.28
	8182093	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.03	CHEMBL4849	Homo sapiens	Inhibition	%	3.03
	8182317	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.14	CHEMBL4849	Homo sapiens	Inhibition	%	3.14
	8182457	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.33	CHEMBL4849	Homo sapiens	Inhibition	%	3.33
	8182773	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.54	CHEMBL4849	Homo sapiens	Inhibition	%	2.54
	8182895	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.25	CHEMBL4849	Homo sapiens	Inhibition	%	1.25
	8183119	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.29	CHEMBL4849	Homo sapiens	Inhibition	%	3.29
	8183268	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.84	CHEMBL4849	Homo sapiens	Inhibition	%	2.84
	8183621	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-5.04	CHEMBL4849	Homo sapiens	Inhibition	%	-5.04
	8183763	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.4	CHEMBL4849	Homo sapiens	Inhibition	%	4.4
	8184123	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.24	CHEMBL4849	Homo sapiens	Inhibition	%	3.24
	8184389	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.97	CHEMBL4849	Homo sapiens	Inhibition	%	4.97
	8184536	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	5.51	CHEMBL4849	Homo sapiens	Inhibition	%	5.51
	8184760	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.22	CHEMBL4849	Homo sapiens	Inhibition	%	2.22
	8184917	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	6.98	CHEMBL4849	Homo sapiens	Inhibition	%	6.98
	8185290	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	4.09	CHEMBL4849	Homo sapiens	Inhibition	%	4.09
	8185421	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	4.35	CHEMBL4849	Homo sapiens	Inhibition	%	4.35
	8185776	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.23	CHEMBL4849	Homo sapiens	Inhibition	%	-0.23
	8185915	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.67	CHEMBL4849	Homo sapiens	Inhibition	%	5.67
	8186139	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.1	CHEMBL4849	Homo sapiens	Inhibition	%	3.1
	8186280	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	3.7	CHEMBL4849	Homo sapiens	Inhibition	%	3.7
	8186668	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.11	CHEMBL4849	Homo sapiens	Inhibition	%	3.11
	8186807	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.76	CHEMBL4849	Homo sapiens	Inhibition	%	2.76
	8187129	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.15	CHEMBL4849	Homo sapiens	Inhibition	%	4.15
	8187477	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.37	CHEMBL4849	Homo sapiens	Inhibition	%	3.37
	8187625	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.42	CHEMBL4849	Homo sapiens	Inhibition	%	2.42
	8187978	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-5.62	CHEMBL4849	Homo sapiens	Inhibition	%	-5.62
	8188121	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.88	CHEMBL4849	Homo sapiens	Inhibition	%	2.88
	8188345	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.63	CHEMBL4849	Homo sapiens	Inhibition	%	3.63
	8188480	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	3.45	CHEMBL4849	Homo sapiens	Inhibition	%	3.45
	8188754	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.06	CHEMBL4849	Homo sapiens	Inhibition	%	6.06
	8189126	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	5.39	CHEMBL4849	Homo sapiens	Inhibition	%	5.39
	8189282	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.83	CHEMBL4849	Homo sapiens	Inhibition	%	4.83
	8189655	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.44	CHEMBL4849	Homo sapiens	Inhibition	%	2.44
	8189787	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.76	CHEMBL4849	Homo sapiens	Inhibition	%	4.76
	8190011	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.44	CHEMBL4849	Homo sapiens	Inhibition	%	3.44
	8190143	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.5	CHEMBL4849	Homo sapiens	Inhibition	%	6.5
	8190507	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	4.53	CHEMBL4849	Homo sapiens	Inhibition	%	4.53
	8190644	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.42	CHEMBL4849	Homo sapiens	Inhibition	%	4.42
	8190868	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.96	CHEMBL4849	Homo sapiens	Inhibition	%	2.96
	8191032	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.74	CHEMBL4849	Homo sapiens	Inhibition	%	3.74
	8191170	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.07	CHEMBL4849	Homo sapiens	Inhibition	%	3.07
	8191394	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.78	CHEMBL4849	Homo sapiens	Inhibition	%	2.78
	8191490	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.89	CHEMBL4849	Homo sapiens	Inhibition	%	3.89
	8191836	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.57	CHEMBL4849	Homo sapiens	Inhibition	%	4.57
	8191985	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.82	CHEMBL4849	Homo sapiens	Inhibition	%	2.82
	8192209	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.39	CHEMBL4849	Homo sapiens	Inhibition	%	2.39
	8192338	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.72	CHEMBL4849	Homo sapiens	Inhibition	%	1.72
	8192706	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.08	CHEMBL4849	Homo sapiens	Inhibition	%	1.08
	8192842	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	2.28	CHEMBL4849	Homo sapiens	Inhibition	%	2.28
	8193066	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.79	CHEMBL4849	Homo sapiens	Inhibition	%	2.79
	8193114	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.39	CHEMBL4849	Homo sapiens	Inhibition	%	4.39
	8193338	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	6.78	CHEMBL4849	Homo sapiens	Inhibition	%	6.78
	8193483	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.72	CHEMBL4849	Homo sapiens	Inhibition	%	2.72
	8193640	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	6.51	CHEMBL4849	Homo sapiens	Inhibition	%	6.51
	8193864	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.33	CHEMBL4849	Homo sapiens	Inhibition	%	4.33
	8194013	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.1	CHEMBL4849	Homo sapiens	Inhibition	%	2.1
	8194368	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.88	CHEMBL4849	Homo sapiens	Inhibition	%	4.88
	8194499	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.62	CHEMBL4849	Homo sapiens	Inhibition	%	3.62
	8194723	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	6.9	CHEMBL4849	Homo sapiens	Inhibition	%	6.9
	8194866	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.98	CHEMBL4849	Homo sapiens	Inhibition	%	3.98
	8195223	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.39	CHEMBL4849	Homo sapiens	Inhibition	%	3.39
	8195387	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.27	CHEMBL4849	Homo sapiens	Inhibition	%	3.27
	8195750	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.26	CHEMBL4849	Homo sapiens	Inhibition	%	3.26
	8195848	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.08	CHEMBL4849	Homo sapiens	Inhibition	%	3.08
	8196072	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.92	CHEMBL4849	Homo sapiens	Inhibition	%	2.92
	8196189	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.7	CHEMBL4849	Homo sapiens	Inhibition	%	3.7
	8196563	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.06	CHEMBL4849	Homo sapiens	Inhibition	%	2.06
	8196691	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-1.14	CHEMBL4849	Homo sapiens	Inhibition	%	-1.14
	8196915	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.64	CHEMBL4849	Homo sapiens	Inhibition	%	1.64
	8197056	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.03	CHEMBL4849	Homo sapiens	Inhibition	%	4.03
	8197417	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.42	CHEMBL4849	Homo sapiens	Inhibition	%	2.42
	8197692	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.73	CHEMBL4849	Homo sapiens	Inhibition	%	4.73
	8197832	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	4.31	CHEMBL4849	Homo sapiens	Inhibition	%	4.31
	8198213	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	5.52	CHEMBL4849	Homo sapiens	Inhibition	%	5.52
	8198351	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.35	CHEMBL4849	Homo sapiens	Inhibition	%	-1.35
	8198705	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.92	CHEMBL4849	Homo sapiens	Inhibition	%	4.92
	8199060	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.24	CHEMBL4849	Homo sapiens	Inhibition	%	4.24
	8199208	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	6.44	CHEMBL4849	Homo sapiens	Inhibition	%	6.44
	8199566	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.36	CHEMBL4849	Homo sapiens	Inhibition	%	2.36
	8199729	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.97	CHEMBL4849	Homo sapiens	Inhibition	%	3.97
	8199953	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	-2.32	CHEMBL4849	Homo sapiens	Inhibition	%	-2.32
	8200091	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.28	CHEMBL4849	Homo sapiens	Inhibition	%	2.28
	8200419	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.07	CHEMBL4849	Homo sapiens	Inhibition	%	2.07
	8200534	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.14	CHEMBL4849	Homo sapiens	Inhibition	%	3.14
	8200758	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.07	CHEMBL4849	Homo sapiens	Inhibition	%	4.07
	8200908	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.94	CHEMBL4849	Homo sapiens	Inhibition	%	2.94
	8201262	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.38	CHEMBL4849	Homo sapiens	Inhibition	%	2.38
	8201397	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.28	CHEMBL4849	Homo sapiens	Inhibition	%	5.28
	8201754	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.37	CHEMBL4849	Homo sapiens	Inhibition	%	2.37
	8202033	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.72	CHEMBL4849	Homo sapiens	Inhibition	%	4.72
	8202173	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.21	CHEMBL4849	Homo sapiens	Inhibition	%	1.21
	8202397	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.05	CHEMBL4849	Homo sapiens	Inhibition	%	2.05
	8202564	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.5	CHEMBL4849	Homo sapiens	Inhibition	%	2.5
	8202689	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.08	CHEMBL4849	Homo sapiens	Inhibition	%	6.08
	8202913	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.43	CHEMBL4849	Homo sapiens	Inhibition	%	4.43
	8203043	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.69	CHEMBL4849	Homo sapiens	Inhibition	%	4.69
	8203398	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	5.3	CHEMBL4849	Homo sapiens	Inhibition	%	5.3
	8203544	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.66	CHEMBL4849	Homo sapiens	Inhibition	%	4.66
	8203768	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.96	CHEMBL4849	Homo sapiens	Inhibition	%	5.96
	8203902	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.64	CHEMBL4849	Homo sapiens	Inhibition	%	2.64
	8204292	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.53	CHEMBL4849	Homo sapiens	Inhibition	%	3.53
	8204429	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.67	CHEMBL4849	Homo sapiens	Inhibition	%	3.67
	8204758	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.34	CHEMBL4849	Homo sapiens	Inhibition	%	1.34
	8205097	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	5.51	CHEMBL4849	Homo sapiens	Inhibition	%	5.51
	8205246	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.89	CHEMBL4849	Homo sapiens	Inhibition	%	3.89
	8205606	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.9	CHEMBL4849	Homo sapiens	Inhibition	%	2.9
	8205745	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.88	CHEMBL4849	Homo sapiens	Inhibition	%	4.88
	8205969	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.87	CHEMBL4849	Homo sapiens	Inhibition	%	4.87
	8206101	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.01	CHEMBL4849	Homo sapiens	Inhibition	%	0.01
	8206377	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.32	CHEMBL4849	Homo sapiens	Inhibition	%	4.32
	8206744	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.46	CHEMBL4849	Homo sapiens	Inhibition	%	-1.46
	8206924	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.28	CHEMBL4849	Homo sapiens	Inhibition	%	6.28
	8207274	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.99	CHEMBL4849	Homo sapiens	Inhibition	%	1.99
	8207404	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.49	CHEMBL4849	Homo sapiens	Inhibition	%	7.49
	8207628	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	13.15	CHEMBL4849	Homo sapiens	Inhibition	%	13.15
	8207760	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.13	CHEMBL4849	Homo sapiens	Inhibition	%	3.13
	8208129	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.47	CHEMBL4849	Homo sapiens	Inhibition	%	1.47
	8208261	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.27	CHEMBL4849	Homo sapiens	Inhibition	%	2.27
	8208651	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	0.42	CHEMBL4849	Homo sapiens	Inhibition	%	0.42
	8208784	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.3	CHEMBL4849	Homo sapiens	Inhibition	%	3.3
	8209008	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.77	CHEMBL4849	Homo sapiens	Inhibition	%	3.77
	8209113	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.63	CHEMBL4849	Homo sapiens	Inhibition	%	1.63
	8209453	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.03	CHEMBL4849	Homo sapiens	Inhibition	%	3.03
	8209603	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	4.77	CHEMBL4849	Homo sapiens	Inhibition	%	4.77
	8209827	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.6	CHEMBL4849	Homo sapiens	Inhibition	%	2.6
	8209963	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.26	CHEMBL4849	Homo sapiens	Inhibition	%	3.26
	8210328	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.36	CHEMBL4849	Homo sapiens	Inhibition	%	4.36
	8210464	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.31	CHEMBL4849	Homo sapiens	Inhibition	%	0.31
	8210723	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	5.57	CHEMBL4849	Homo sapiens	Inhibition	%	5.57
	8211091	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	6.92	CHEMBL4849	Homo sapiens	Inhibition	%	6.92
	8211261	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.98	CHEMBL4849	Homo sapiens	Inhibition	%	1.98
	8211485	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.67	CHEMBL4849	Homo sapiens	Inhibition	%	4.67
	8211608	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.09	CHEMBL4849	Homo sapiens	Inhibition	%	4.09
	8211961	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	46.3	CHEMBL4849	Homo sapiens	Inhibition	%	46.3
	8212093	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.92	CHEMBL4849	Homo sapiens	Inhibition	%	5.92
	8212458	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.51	CHEMBL4849	Homo sapiens	Inhibition	%	5.51
	8212591	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.19	CHEMBL4849	Homo sapiens	Inhibition	%	3.19
	8212815	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.29	CHEMBL4849	Homo sapiens	Inhibition	%	4.29
	8212985	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.79	CHEMBL4849	Homo sapiens	Inhibition	%	1.79
	8213338	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.89	CHEMBL4849	Homo sapiens	Inhibition	%	2.89
	8213442	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.61	CHEMBL4849	Homo sapiens	Inhibition	%	-0.61
	8213666	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.15	CHEMBL4849	Homo sapiens	Inhibition	%	-1.15
	8213779	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.77	CHEMBL4849	Homo sapiens	Inhibition	%	2.77
	8214150	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.74	CHEMBL4849	Homo sapiens	Inhibition	%	1.74
	8214287	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.58	CHEMBL4849	Homo sapiens	Inhibition	%	3.58
	8214645	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	4.63	CHEMBL4849	Homo sapiens	Inhibition	%	4.63
	8214797	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-4.11	CHEMBL4849	Homo sapiens	Inhibition	%	-4.11
	8215021	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-5.33	CHEMBL4849	Homo sapiens	Inhibition	%	-5.33
	8215048	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	3.78	CHEMBL4849	Homo sapiens	Inhibition	%	3.78
	8215272	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	5.79	CHEMBL4849	Homo sapiens	Inhibition	%	5.79
	8215425	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.66	CHEMBL4849	Homo sapiens	Inhibition	%	4.66
	8215813	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.63	CHEMBL4849	Homo sapiens	Inhibition	%	3.63
	8215932	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.49	CHEMBL4849	Homo sapiens	Inhibition	%	5.49
	8216275	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.57	CHEMBL4849	Homo sapiens	Inhibition	%	5.57
	8216411	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.78	CHEMBL4849	Homo sapiens	Inhibition	%	3.78
	8216635	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.62	CHEMBL4849	Homo sapiens	Inhibition	%	5.62
	8216773	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.0	CHEMBL4849	Homo sapiens	Inhibition	%	3.0
	8217131	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	4.11	CHEMBL4849	Homo sapiens	Inhibition	%	4.11
	8217305	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1	Outside typical range	CHEMBL1909341	=	Inhibition	%	-31.71	CHEMBL4849	Homo sapiens	Inhibition	%	-31.71
	8217660	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.85	CHEMBL4849	Homo sapiens	Inhibition	%	4.85
	8217985	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.67	CHEMBL4849	Homo sapiens	Inhibition	%	-3.67
	8218100	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.62	CHEMBL4849	Homo sapiens	Inhibition	%	1.62
	8218451	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.99	CHEMBL4849	Homo sapiens	Inhibition	%	3.99
	8218594	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.26	CHEMBL4849	Homo sapiens	Inhibition	%	4.26
	8218818	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.58	CHEMBL4849	Homo sapiens	Inhibition	%	3.58
	8218949	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	4.4	CHEMBL4849	Homo sapiens	Inhibition	%	4.4
	8219333	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-3.67	CHEMBL4849	Homo sapiens	Inhibition	%	-3.67
	8219583	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.4	CHEMBL4849	Homo sapiens	Inhibition	%	4.4
	8219744	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	6.65	CHEMBL4849	Homo sapiens	Inhibition	%	6.65
	8220137	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.19	CHEMBL4849	Homo sapiens	Inhibition	%	5.19
	8220266	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	3.45	CHEMBL4849	Homo sapiens	Inhibition	%	3.45
	8220490	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.68	CHEMBL4849	Homo sapiens	Inhibition	%	5.68
	8220604	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.81	CHEMBL4849	Homo sapiens	Inhibition	%	3.81
	8220966	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.31	CHEMBL4849	Homo sapiens	Inhibition	%	4.31
	8221102	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.5	CHEMBL4849	Homo sapiens	Inhibition	%	4.5
	8221326	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.28	CHEMBL4849	Homo sapiens	Inhibition	%	3.28
	8221459	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.58	CHEMBL4849	Homo sapiens	Inhibition	%	3.58
	8221624	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.97	CHEMBL4849	Homo sapiens	Inhibition	%	1.97
	8221848	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.15	CHEMBL4849	Homo sapiens	Inhibition	%	0.15
	8221979	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.13	CHEMBL4849	Homo sapiens	Inhibition	%	3.13
	8222301	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.79	CHEMBL4849	Homo sapiens	Inhibition	%	2.79
	8222435	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.67	CHEMBL4849	Homo sapiens	Inhibition	%	2.67
	8222659	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.06	CHEMBL4849	Homo sapiens	Inhibition	%	2.06
	8222777	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	-1.23	CHEMBL4849	Homo sapiens	Inhibition	%	-1.23
	8223145	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	-1.9	CHEMBL4849	Homo sapiens	Inhibition	%	-1.9
	8223274	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.29	CHEMBL4849	Homo sapiens	Inhibition	%	4.29
	8223498	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.36	CHEMBL4849	Homo sapiens	Inhibition	%	4.36
	8223659	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.81	CHEMBL4849	Homo sapiens	Inhibition	%	2.81
	8223909	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	5.77	CHEMBL4849	Homo sapiens	Inhibition	%	5.77
	8224071	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.79	CHEMBL4849	Homo sapiens	Inhibition	%	4.79
	8224295	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	6.37	CHEMBL4849	Homo sapiens	Inhibition	%	6.37
	8224465	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.92	CHEMBL4849	Homo sapiens	Inhibition	%	4.92
	8224824	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.65	CHEMBL4849	Homo sapiens	Inhibition	%	3.65
	8224938	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.35	CHEMBL4849	Homo sapiens	Inhibition	%	4.35
	8225162	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.32	CHEMBL4849	Homo sapiens	Inhibition	%	3.32
	8225296	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.05	CHEMBL4849	Homo sapiens	Inhibition	%	6.05
	8225658	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	4.7	CHEMBL4849	Homo sapiens	Inhibition	%	4.7
	8225793	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.43	CHEMBL4849	Homo sapiens	Inhibition	%	3.43
	8226175	CHEMBL1962093	GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.13	CHEMBL4849	Homo sapiens	Inhibition	%	0.13
	8226300	CHEMBL1962092	GSK_PKIS: NEK7 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.1	CHEMBL4849	Homo sapiens	Inhibition	%	3.1
	10839424	CHEMBL2015409	Inhibition of NEK7 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL4849	Homo sapiens	INH	%	0.0
	12047283	CHEMBL2157308	Inhibition of NEK7 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-2.0	CHEMBL4849	Homo sapiens	INH	%	-2.0
	12172313	CHEMBL2215428	Inhibition of NEK7 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	12207226	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	114.0	CHEMBL4849	Homo sapiens	Residual Activity	%	114.0
	12207227	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207228	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	95.0	CHEMBL4849	Homo sapiens	Residual Activity	%	95.0
	12207229	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	108.0	CHEMBL4849	Homo sapiens	Residual Activity	%	108.0
	12207230	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12207231	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	87.0	CHEMBL4849	Homo sapiens	Residual Activity	%	87.0
	12207232	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12207233	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207234	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207235	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12207236	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12207237	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12207238	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	89.0	CHEMBL4849	Homo sapiens	Residual Activity	%	89.0
	12207239	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	90.0	CHEMBL4849	Homo sapiens	Residual Activity	%	90.0
	12207240	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	93.0	CHEMBL4849	Homo sapiens	Residual Activity	%	93.0
	12207241	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12207242	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	117.0	CHEMBL4849	Homo sapiens	Residual Activity	%	117.0
	12207243	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12207244	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	87.0	CHEMBL4849	Homo sapiens	Residual Activity	%	87.0
	12207245	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	87.0	CHEMBL4849	Homo sapiens	Residual Activity	%	87.0
	12207246	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	91.0	CHEMBL4849	Homo sapiens	Residual Activity	%	91.0
	12207247	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	98.0	CHEMBL4849	Homo sapiens	Residual Activity	%	98.0
	12207248	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	99.0	CHEMBL4849	Homo sapiens	Residual Activity	%	99.0
	12207249	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12207250	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	108.0	CHEMBL4849	Homo sapiens	Residual Activity	%	108.0
	12207251	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207252	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	95.0	CHEMBL4849	Homo sapiens	Residual Activity	%	95.0
	12207253	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	99.0	CHEMBL4849	Homo sapiens	Residual Activity	%	99.0
	12207254	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	97.0	CHEMBL4849	Homo sapiens	Residual Activity	%	97.0
	12207255	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	117.0	CHEMBL4849	Homo sapiens	Residual Activity	%	117.0
	12207256	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	98.0	CHEMBL4849	Homo sapiens	Residual Activity	%	98.0
	12207257	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	98.0	CHEMBL4849	Homo sapiens	Residual Activity	%	98.0
	12207258	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12207259	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12207260	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12207261	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12207262	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	92.0	CHEMBL4849	Homo sapiens	Residual Activity	%	92.0
	12207263	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	97.0	CHEMBL4849	Homo sapiens	Residual Activity	%	97.0
	12207264	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12207265	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207266	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	116.0	CHEMBL4849	Homo sapiens	Residual Activity	%	116.0
	12207267	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	98.0	CHEMBL4849	Homo sapiens	Residual Activity	%	98.0
	12207268	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	95.0	CHEMBL4849	Homo sapiens	Residual Activity	%	95.0
	12207269	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207270	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	98.0	CHEMBL4849	Homo sapiens	Residual Activity	%	98.0
	12207271	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	95.0	CHEMBL4849	Homo sapiens	Residual Activity	%	95.0
	12207272	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	97.0	CHEMBL4849	Homo sapiens	Residual Activity	%	97.0
	12207273	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207274	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	116.0	CHEMBL4849	Homo sapiens	Residual Activity	%	116.0
	12207275	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12207276	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	93.0	CHEMBL4849	Homo sapiens	Residual Activity	%	93.0
	12207277	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	97.0	CHEMBL4849	Homo sapiens	Residual Activity	%	97.0
	12207278	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	84.0	CHEMBL4849	Homo sapiens	Residual Activity	%	84.0
	12207279	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	88.0	CHEMBL4849	Homo sapiens	Residual Activity	%	88.0
	12207280	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207281	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12207282	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	125.0	CHEMBL4849	Homo sapiens	Residual Activity	%	125.0
	12207283	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12207284	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12207285	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	98.0	CHEMBL4849	Homo sapiens	Residual Activity	%	98.0
	12207286	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12207287	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	91.0	CHEMBL4849	Homo sapiens	Residual Activity	%	91.0
	12207288	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	116.0	CHEMBL4849	Homo sapiens	Residual Activity	%	116.0
	12207289	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	116.0	CHEMBL4849	Homo sapiens	Residual Activity	%	116.0
	12207290	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	117.0	CHEMBL4849	Homo sapiens	Residual Activity	%	117.0
	12207291	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	118.0	CHEMBL4849	Homo sapiens	Residual Activity	%	118.0
	12207292	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	89.0	CHEMBL4849	Homo sapiens	Residual Activity	%	89.0
	12207293	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12207294	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12207295	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	97.0	CHEMBL4849	Homo sapiens	Residual Activity	%	97.0
	12207296	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12207297	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12207298	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	117.0	CHEMBL4849	Homo sapiens	Residual Activity	%	117.0
	12207299	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	98.0	CHEMBL4849	Homo sapiens	Residual Activity	%	98.0
	12207300	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	83.0	CHEMBL4849	Homo sapiens	Residual Activity	%	83.0
	12207301	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207302	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12207303	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207304	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	109.0	CHEMBL4849	Homo sapiens	Residual Activity	%	109.0
	12207305	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	93.0	CHEMBL4849	Homo sapiens	Residual Activity	%	93.0
	12207306	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12207307	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12207308	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12207309	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12207310	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12207311	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207312	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12207313	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207314	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	109.0	CHEMBL4849	Homo sapiens	Residual Activity	%	109.0
	12207315	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12207316	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12207317	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12207318	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	105.0	CHEMBL4849	Homo sapiens	Residual Activity	%	105.0
	12207319	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	97.0	CHEMBL4849	Homo sapiens	Residual Activity	%	97.0
	12207320	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207321	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	116.0	CHEMBL4849	Homo sapiens	Residual Activity	%	116.0
	12207322	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	108.0	CHEMBL4849	Homo sapiens	Residual Activity	%	108.0
	12207323	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	114.0	CHEMBL4849	Homo sapiens	Residual Activity	%	114.0
	12207324	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	109.0	CHEMBL4849	Homo sapiens	Residual Activity	%	109.0
	12207325	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12207326	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12207327	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12207328	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12207329	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	107.0	CHEMBL4849	Homo sapiens	Residual Activity	%	107.0
	12207330	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12207331	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207332	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12207333	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12207334	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	114.0	CHEMBL4849	Homo sapiens	Residual Activity	%	114.0
	12207335	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12207336	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	99.0	CHEMBL4849	Homo sapiens	Residual Activity	%	99.0
	12207337	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	107.0	CHEMBL4849	Homo sapiens	Residual Activity	%	107.0
	12207338	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	112.0	CHEMBL4849	Homo sapiens	Residual Activity	%	112.0
	12207339	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	112.0	CHEMBL4849	Homo sapiens	Residual Activity	%	112.0
	12207340	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207341	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12207342	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207343	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12207344	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	109.0	CHEMBL4849	Homo sapiens	Residual Activity	%	109.0
	12207345	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	126.0	CHEMBL4849	Homo sapiens	Residual Activity	%	126.0
	12207346	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	116.0	CHEMBL4849	Homo sapiens	Residual Activity	%	116.0
	12207347	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207348	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207349	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207350	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12207351	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207352	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207353	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	110.0	CHEMBL4849	Homo sapiens	Residual Activity	%	110.0
	12207354	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	107.0	CHEMBL4849	Homo sapiens	Residual Activity	%	107.0
	12207355	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207356	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12207357	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12207358	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	99.0	CHEMBL4849	Homo sapiens	Residual Activity	%	99.0
	12207359	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	110.0	CHEMBL4849	Homo sapiens	Residual Activity	%	110.0
	12207360	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	114.0	CHEMBL4849	Homo sapiens	Residual Activity	%	114.0
	12207361	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	108.0	CHEMBL4849	Homo sapiens	Residual Activity	%	108.0
	12207362	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12207363	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	98.0	CHEMBL4849	Homo sapiens	Residual Activity	%	98.0
	12207364	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207365	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	107.0	CHEMBL4849	Homo sapiens	Residual Activity	%	107.0
	12207366	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207367	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	115.0	CHEMBL4849	Homo sapiens	Residual Activity	%	115.0
	12207368	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	114.0	CHEMBL4849	Homo sapiens	Residual Activity	%	114.0
	12207369	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12207370	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12207371	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	87.0	CHEMBL4849	Homo sapiens	Residual Activity	%	87.0
	12207372	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	98.0	CHEMBL4849	Homo sapiens	Residual Activity	%	98.0
	12207373	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12207374	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12207375	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12207376	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	117.0	CHEMBL4849	Homo sapiens	Residual Activity	%	117.0
	12207377	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	108.0	CHEMBL4849	Homo sapiens	Residual Activity	%	108.0
	12207378	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	93.0	CHEMBL4849	Homo sapiens	Residual Activity	%	93.0
	12207379	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	108.0	CHEMBL4849	Homo sapiens	Residual Activity	%	108.0
	12207380	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207381	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12207382	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	114.0	CHEMBL4849	Homo sapiens	Residual Activity	%	114.0
	12207383	CHEMBL2219353	Millipore: Percentage of residual kinase activity of NEK7 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	112.0	CHEMBL4849	Homo sapiens	Residual Activity	%	112.0
	12207384	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	116.0	CHEMBL4849	Homo sapiens	Residual Activity	%	116.0
	12207385	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207386	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	93.0	CHEMBL4849	Homo sapiens	Residual Activity	%	93.0
	12207387	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207388	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	95.0	CHEMBL4849	Homo sapiens	Residual Activity	%	95.0
	12207389	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	85.0	CHEMBL4849	Homo sapiens	Residual Activity	%	85.0
	12207390	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	89.0	CHEMBL4849	Homo sapiens	Residual Activity	%	89.0
	12207391	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	115.0	CHEMBL4849	Homo sapiens	Residual Activity	%	115.0
	12207392	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	107.0	CHEMBL4849	Homo sapiens	Residual Activity	%	107.0
	12207393	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12207394	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12207395	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12207396	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	114.0	CHEMBL4849	Homo sapiens	Residual Activity	%	114.0
	12207397	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12207398	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	125.0	CHEMBL4849	Homo sapiens	Residual Activity	%	125.0
	12207399	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	110.0	CHEMBL4849	Homo sapiens	Residual Activity	%	110.0
	12207400	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	138.0	CHEMBL4849	Homo sapiens	Residual Activity	%	138.0
	12207401	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	137.0	CHEMBL4849	Homo sapiens	Residual Activity	%	137.0
	12207402	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	83.0	CHEMBL4849	Homo sapiens	Residual Activity	%	83.0
	12207403	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12207404	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	93.0	CHEMBL4849	Homo sapiens	Residual Activity	%	93.0
	12207405	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	98.0	CHEMBL4849	Homo sapiens	Residual Activity	%	98.0
	12207406	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	114.0	CHEMBL4849	Homo sapiens	Residual Activity	%	114.0
	12207407	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	120.0	CHEMBL4849	Homo sapiens	Residual Activity	%	120.0
	12207408	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207409	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12207410	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	99.0	CHEMBL4849	Homo sapiens	Residual Activity	%	99.0
	12207411	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12207412	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	113.0	CHEMBL4849	Homo sapiens	Residual Activity	%	113.0
	12207413	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	92.0	CHEMBL4849	Homo sapiens	Residual Activity	%	92.0
	12207414	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	118.0	CHEMBL4849	Homo sapiens	Residual Activity	%	118.0
	12207415	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12207416	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	69.0	CHEMBL4849	Homo sapiens	Residual Activity	%	69.0
	12207417	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	95.0	CHEMBL4849	Homo sapiens	Residual Activity	%	95.0
	12207418	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	90.0	CHEMBL4849	Homo sapiens	Residual Activity	%	90.0
	12207419	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	91.0	CHEMBL4849	Homo sapiens	Residual Activity	%	91.0
	12207420	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	113.0	CHEMBL4849	Homo sapiens	Residual Activity	%	113.0
	12207421	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	115.0	CHEMBL4849	Homo sapiens	Residual Activity	%	115.0
	12207422	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	95.0	CHEMBL4849	Homo sapiens	Residual Activity	%	95.0
	12207423	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12210261	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	115.0	CHEMBL4849	Homo sapiens	Residual Activity	%	115.0
	12210262	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	124.0	CHEMBL4849	Homo sapiens	Residual Activity	%	124.0
	12210263	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	80.0	CHEMBL4849	Homo sapiens	Residual Activity	%	80.0
	12210264	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	99.0	CHEMBL4849	Homo sapiens	Residual Activity	%	99.0
	12210265	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	91.0	CHEMBL4849	Homo sapiens	Residual Activity	%	91.0
	12210266	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	95.0	CHEMBL4849	Homo sapiens	Residual Activity	%	95.0
	12210267	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12210268	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12210269	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	105.0	CHEMBL4849	Homo sapiens	Residual Activity	%	105.0
	12210270	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12210271	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12210272	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	105.0	CHEMBL4849	Homo sapiens	Residual Activity	%	105.0
	12210273	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	63.0	CHEMBL4849	Homo sapiens	Residual Activity	%	63.0
	12210274	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	98.0	CHEMBL4849	Homo sapiens	Residual Activity	%	98.0
	12210275	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	125.0	CHEMBL4849	Homo sapiens	Residual Activity	%	125.0
	12210276	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	114.0	CHEMBL4849	Homo sapiens	Residual Activity	%	114.0
	12210277	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	86.0	CHEMBL4849	Homo sapiens	Residual Activity	%	86.0
	12210278	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12210279	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	93.0	CHEMBL4849	Homo sapiens	Residual Activity	%	93.0
	12210280	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	91.0	CHEMBL4849	Homo sapiens	Residual Activity	%	91.0
	12210281	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	138.0	CHEMBL4849	Homo sapiens	Residual Activity	%	138.0
	12210282	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	82.0	CHEMBL4849	Homo sapiens	Residual Activity	%	82.0
	12210283	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	108.0	CHEMBL4849	Homo sapiens	Residual Activity	%	108.0
	12210284	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12210285	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12210286	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	116.0	CHEMBL4849	Homo sapiens	Residual Activity	%	116.0
	12210287	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	76.0	CHEMBL4849	Homo sapiens	Residual Activity	%	76.0
	12210288	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	95.0	CHEMBL4849	Homo sapiens	Residual Activity	%	95.0
	12210289	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12210290	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	112.0	CHEMBL4849	Homo sapiens	Residual Activity	%	112.0
	12210291	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12210292	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12210293	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	121.0	CHEMBL4849	Homo sapiens	Residual Activity	%	121.0
	12210294	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	89.0	CHEMBL4849	Homo sapiens	Residual Activity	%	89.0
	12210295	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	82.0	CHEMBL4849	Homo sapiens	Residual Activity	%	82.0
	12210296	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	119.0	CHEMBL4849	Homo sapiens	Residual Activity	%	119.0
	12210297	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	97.0	CHEMBL4849	Homo sapiens	Residual Activity	%	97.0
	12210298	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	109.0	CHEMBL4849	Homo sapiens	Residual Activity	%	109.0
	12210299	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	110.0	CHEMBL4849	Homo sapiens	Residual Activity	%	110.0
	12210300	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	114.0	CHEMBL4849	Homo sapiens	Residual Activity	%	114.0
	12210301	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12210302	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	105.0	CHEMBL4849	Homo sapiens	Residual Activity	%	105.0
	12210303	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	89.0	CHEMBL4849	Homo sapiens	Residual Activity	%	89.0
	12210304	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	112.0	CHEMBL4849	Homo sapiens	Residual Activity	%	112.0
	12210305	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12210306	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	114.0	CHEMBL4849	Homo sapiens	Residual Activity	%	114.0
	12210307	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	118.0	CHEMBL4849	Homo sapiens	Residual Activity	%	118.0
	12210308	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	116.0	CHEMBL4849	Homo sapiens	Residual Activity	%	116.0
	12210309	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	140.0	CHEMBL4849	Homo sapiens	Residual Activity	%	140.0
	12210310	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12210311	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	97.0	CHEMBL4849	Homo sapiens	Residual Activity	%	97.0
	12210312	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12210313	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	84.0	CHEMBL4849	Homo sapiens	Residual Activity	%	84.0
	12210314	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	93.0	CHEMBL4849	Homo sapiens	Residual Activity	%	93.0
	12210315	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	105.0	CHEMBL4849	Homo sapiens	Residual Activity	%	105.0
	12210316	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	110.0	CHEMBL4849	Homo sapiens	Residual Activity	%	110.0
	12210317	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12210318	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	87.0	CHEMBL4849	Homo sapiens	Residual Activity	%	87.0
	12210319	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	92.0	CHEMBL4849	Homo sapiens	Residual Activity	%	92.0
	12210320	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12210321	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	86.0	CHEMBL4849	Homo sapiens	Residual Activity	%	86.0
	12210322	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	95.0	CHEMBL4849	Homo sapiens	Residual Activity	%	95.0
	12210323	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12210324	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	110.0	CHEMBL4849	Homo sapiens	Residual Activity	%	110.0
	12210325	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12210326	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	95.0	CHEMBL4849	Homo sapiens	Residual Activity	%	95.0
	12210327	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	105.0	CHEMBL4849	Homo sapiens	Residual Activity	%	105.0
	12210328	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12210329	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	86.0	CHEMBL4849	Homo sapiens	Residual Activity	%	86.0
	12210330	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12210331	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12210332	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12210333	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12210334	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	142.0	CHEMBL4849	Homo sapiens	Residual Activity	%	142.0
	12210335	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12210336	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	97.0	CHEMBL4849	Homo sapiens	Residual Activity	%	97.0
	12210337	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12210338	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	93.0	CHEMBL4849	Homo sapiens	Residual Activity	%	93.0
	12210339	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	102.0	CHEMBL4849	Homo sapiens	Residual Activity	%	102.0
	12210340	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	120.0	CHEMBL4849	Homo sapiens	Residual Activity	%	120.0
	12210341	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	108.0	CHEMBL4849	Homo sapiens	Residual Activity	%	108.0
	12210342	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	112.0	CHEMBL4849	Homo sapiens	Residual Activity	%	112.0
	12210343	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	84.0	CHEMBL4849	Homo sapiens	Residual Activity	%	84.0
	12210344	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	81.0	CHEMBL4849	Homo sapiens	Residual Activity	%	81.0
	12210345	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	85.0	CHEMBL4849	Homo sapiens	Residual Activity	%	85.0
	12210346	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	97.0	CHEMBL4849	Homo sapiens	Residual Activity	%	97.0
	12210347	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12210348	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	106.0	CHEMBL4849	Homo sapiens	Residual Activity	%	106.0
	12210349	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	112.0	CHEMBL4849	Homo sapiens	Residual Activity	%	112.0
	12210350	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	82.0	CHEMBL4849	Homo sapiens	Residual Activity	%	82.0
	12210351	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	86.0	CHEMBL4849	Homo sapiens	Residual Activity	%	86.0
	12210352	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12210353	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	89.0	CHEMBL4849	Homo sapiens	Residual Activity	%	89.0
	12210354	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12210355	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	113.0	CHEMBL4849	Homo sapiens	Residual Activity	%	113.0
	12210356	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	107.0	CHEMBL4849	Homo sapiens	Residual Activity	%	107.0
	12210357	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	94.0	CHEMBL4849	Homo sapiens	Residual Activity	%	94.0
	12210358	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	82.0	CHEMBL4849	Homo sapiens	Residual Activity	%	82.0
	12210359	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	85.0	CHEMBL4849	Homo sapiens	Residual Activity	%	85.0
	12210360	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	86.0	CHEMBL4849	Homo sapiens	Residual Activity	%	86.0
	12210361	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	90.0	CHEMBL4849	Homo sapiens	Residual Activity	%	90.0
	12210362	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12210363	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	108.0	CHEMBL4849	Homo sapiens	Residual Activity	%	108.0
	12210364	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12210365	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12210366	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	84.0	CHEMBL4849	Homo sapiens	Residual Activity	%	84.0
	12210367	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	111.0	CHEMBL4849	Homo sapiens	Residual Activity	%	111.0
	12210368	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	86.0	CHEMBL4849	Homo sapiens	Residual Activity	%	86.0
	12210369	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	96.0	CHEMBL4849	Homo sapiens	Residual Activity	%	96.0
	12210370	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	104.0	CHEMBL4849	Homo sapiens	Residual Activity	%	104.0
	12210371	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	101.0	CHEMBL4849	Homo sapiens	Residual Activity	%	101.0
	12210372	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	121.0	CHEMBL4849	Homo sapiens	Residual Activity	%	121.0
	12210373	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	90.0	CHEMBL4849	Homo sapiens	Residual Activity	%	90.0
	12210374	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12210375	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	100.0	CHEMBL4849	Homo sapiens	Residual Activity	%	100.0
	12210376	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	117.0	CHEMBL4849	Homo sapiens	Residual Activity	%	117.0
	12210377	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	103.0	CHEMBL4849	Homo sapiens	Residual Activity	%	103.0
	12210378	CHEMBL2219354	Millipore: Percentage of residual kinase activity of NEK7 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	108.0	CHEMBL4849	Homo sapiens	Residual Activity	%	108.0
	12693200	CHEMBL2343443	Inhibition of NEK7 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4849	Homo sapiens	IC50	nM	10000.0
	12727709	CHEMBL2350887	Inhibition of NEK7 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	99.0	CHEMBL4849	Homo sapiens	Activity	%	99.0
	12728997	CHEMBL2350174	Inhibition of NEK7 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	87.0	CHEMBL4849	Homo sapiens	Activity	%	87.0
	12729883	CHEMBL2349787	Inhibition of NEK7 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	101.0	CHEMBL4849	Homo sapiens	Activity	%	101.0
	12730140	CHEMBL2350887	Inhibition of NEK7 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL4849	Homo sapiens	Activity	%	96.0
	13374422	CHEMBL2406674	Inhibition of NEK7 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	6.0	CHEMBL4849	Homo sapiens	INH	%	6.0
	13434666	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13434667	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13434668	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13434669	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13434670	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13434671	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13434672	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13434673	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13434674	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13434675	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13434676	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13434677	CHEMBL2424429	Inhibition of NEK7 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL4849	Homo sapiens	INH	%	35.0
	13439719	CHEMBL2428035	Competitive binding affinity to NEK7 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	13442410	CHEMBL2428035	Competitive binding affinity to NEK7 (unknown origin) at 10 uM in presence of ATP relative to control	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	>	Inhibition	%	85.0	CHEMBL4849	Homo sapiens	INH	%	85.0
	13442482	CHEMBL2429176	Binding affinity to NEK7 (unknown origin)	B	CS(=O)(=O)CCCOc1cccc2c1ccn2-c1ccnc(N[C@H]2CC[C@H](C(=O)N3CCC(O)CC3)CC2)n1		CHEMBL2425628	=	Kd	nM	6900.0	CHEMBL4849	Homo sapiens	Kd	uM	6.9
	13445552	CHEMBL2428035	Competitive binding affinity to NEK7 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	13451539	CHEMBL2428035	Competitive binding affinity to NEK7 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	93.0	CHEMBL4849	Homo sapiens	INH	%	93.0
	13872078	CHEMBL3101263	Inhibition of human NEK7 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	57.0	CHEMBL4849	Homo sapiens	Activity	%	57.0
	14582572	CHEMBL3241636	Inhibition of human NEK7 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	109.5	CHEMBL4849	Homo sapiens	Activity	%	109.5
	15756886	CHEMBL3630742	Inhibition of NEK7 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1	Outside typical range	CHEMBL166031	=	Inhibition	%	-65.91	CHEMBL4849	Homo sapiens	INH	%	-65.91
	15757837	CHEMBL3630742	Inhibition of NEK7 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	33.73	CHEMBL4849	Homo sapiens	INH	%	33.73
	15758816	CHEMBL3630742	Inhibition of NEK7 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	6.02	CHEMBL4849	Homo sapiens	INH	%	6.02
	16431932	CHEMBL3748025	Inhibition of human NEK7 using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4849	Homo sapiens	IC50	uM	10.0
	16451541	CHEMBL3760664	Inhibition of NEK7 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	8.4	CHEMBL4849	Homo sapiens	INH	%	8.4
	16495151	CHEMBL3777730	Inhibition of N-terminal His6-tagged recombinant human NEK7 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-20.0	CHEMBL4849	Homo sapiens	Activity	%	-20.0
	16496070	CHEMBL3777730	Inhibition of N-terminal His6-tagged recombinant human NEK7 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-10.0	CHEMBL4849	Homo sapiens	Activity	%	-10.0
	16508257	CHEMBL3777730	Inhibition of N-terminal His6-tagged recombinant human NEK7 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-28.0	CHEMBL4849	Homo sapiens	Activity	%	-28.0
	16612621	CHEMBL3815492	Inhibition of NEK7 (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-2.0	CHEMBL4849	Homo sapiens	Activity	%	-2.0
	16612622	CHEMBL3815492	Inhibition of NEK7 (unknown origin) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	4.0	CHEMBL4849	Homo sapiens	Activity	%	4.0
	16614563	CHEMBL3817594	Inhibition of human NEK7 at 1 uM using MBP as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	Outside typical range	CHEMBL3815093	=	Inhibition	%	-11.0	CHEMBL4849	Homo sapiens	INH	%	-11.0
	16618144	CHEMBL3817341	Inhibition of full length recombinant human GST-tagged NEK7 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
Inactive	17921571	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921572	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17921573	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	3.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	3.0
Inactive	17921574	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921575	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921576	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921577	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921578	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921579	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Active	17921580	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	2126.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	2126.0
Inactive	17921581	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921582	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921583	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921584	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921585	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921586	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921587	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921588	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921589	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921590	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921591	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921592	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921593	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921594	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921595	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921596	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921597	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921598	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921599	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921600	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921601	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921602	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921603	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921604	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921605	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921606	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921607	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921608	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921609	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921610	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921611	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921612	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921613	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921614	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921615	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921616	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921617	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921618	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921619	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921620	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921621	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921622	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921623	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921624	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921625	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921626	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921627	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921628	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921629	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921630	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921631	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921632	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921633	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921634	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921635	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921636	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921637	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921638	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921639	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921640	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921641	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921642	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921643	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921644	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921645	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921646	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921647	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921648	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921649	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921650	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921651	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921652	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921653	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921654	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921655	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921656	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921657	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921658	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921659	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921660	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921661	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921662	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921663	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921664	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921665	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921666	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921667	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921668	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921669	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921670	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921671	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921672	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921673	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921674	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921675	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921676	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921677	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921678	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921679	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921680	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921681	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921682	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921683	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921684	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921685	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921686	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921687	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921688	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921689	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921690	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921691	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921692	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921693	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921694	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921695	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921696	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921697	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921698	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921699	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921700	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921701	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921702	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921703	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921704	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921705	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921706	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921707	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921708	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17921709	CHEMBL3991801	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4849	Homo sapiens	Kd apparent	nM	30000.0
	18114218	CHEMBL4025276	Inhibition of wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	95.0	CHEMBL4849	Homo sapiens	Activity	%	95.0
	18153057	CHEMBL4034426	Inhibition of NEK7 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	2.1	CHEMBL4849	Homo sapiens	INH	%	2.1
	18153260	CHEMBL4034427	Inhibition of NEK7 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-6.5	CHEMBL4849	Homo sapiens	INH	%	-6.5
	18203800	CHEMBL4044087	Inhibition of wild-type human full length NEK7 (M1 to S302 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	18211529	CHEMBL4045778	Inhibition of NEK7 conserved Lys1 (AACLLDGVPVALKK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	2.1	CHEMBL4849	Homo sapiens	INH	%	2.1
	18211530	CHEMBL4045777	Inhibition of NEK7 conserved Lys2 (DIKPANVFITATGVVK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-9.6	CHEMBL4849	Homo sapiens	INH	%	-9.6
	18211922	CHEMBL4046018	Inhibition of NEK7 conserved Lys2 (DIKPANVFITATGVVK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-4.8	CHEMBL4849	Homo sapiens	INH	%	-4.8
	18211923	CHEMBL4046019	Inhibition of NEK7 conserved Lys1 (AACLLDGVPVALKK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	7.6	CHEMBL4849	Homo sapiens	INH	%	7.6
	18253885	CHEMBL4055227	Inhibition of wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	18253886	CHEMBL4055227	Inhibition of wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	18275145	CHEMBL4118427	Inhibition of NEK7 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPANVFITATGVVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-36.1	CHEMBL4849	Homo sapiens	INH	%	-36.1
	18275146	CHEMBL4118427	Inhibition of NEK7 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPANVFITATGVVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	-0.4	CHEMBL4849	Homo sapiens	INH	%	-0.4
	18275147	CHEMBL4118427	Inhibition of NEK7 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPANVFITATGVVK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	4.9	CHEMBL4849	Homo sapiens	INH	%	4.9
	18275148	CHEMBL4118428	Inhibition of NEK7 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled AACLLDGVPVALKK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-28.6	CHEMBL4849	Homo sapiens	INH	%	-28.6
	18275149	CHEMBL4118428	Inhibition of NEK7 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled AACLLDGVPVALKK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-12.6	CHEMBL4849	Homo sapiens	INH	%	-12.6
	18275150	CHEMBL4118428	Inhibition of NEK7 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled AACLLDGVPVALKK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-28.5	CHEMBL4849	Homo sapiens	INH	%	-28.5
	18440342	CHEMBL4157166	Binding affinity to wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	78.0	CHEMBL4849	Homo sapiens	Activity	%	78.0
	18484298	CHEMBL4185945	Binding affinity to wild-type human full length NEK7 (M1 to S302 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	18484782	CHEMBL4185945	Binding affinity to wild-type human full length NEK7 (M1 to S302 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	95.0	CHEMBL4849	Homo sapiens	Activity	%	95.0
	18507965	CHEMBL4191085	Inhibition of recombinant human NEK7 (2 to end residues) at 1 uM using FLAKSFGSPNRAYKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-1.0	CHEMBL4849	Homo sapiens	INH	%	-1.0
	18653485	CHEMBL4230161	Inhibition of NEK7 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	1.0	CHEMBL4849	Homo sapiens	INH	%	1.0
	18653486	CHEMBL4230161	Inhibition of NEK7 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-2.0	CHEMBL4849	Homo sapiens	INH	%	-2.0
	18655390	CHEMBL4230845	Binding affinity to wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	96.0	CHEMBL4849	Homo sapiens	Activity	%	96.0
	18751171	CHEMBL4263880	Inhibition of NEK7 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	0.0	CHEMBL4849	Homo sapiens	INH	%	0.0
	18752097	CHEMBL4264434	Binding affinity to wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	83.0	CHEMBL4849	Homo sapiens	Activity	%	83.0
	18858098	CHEMBL4307944	Binding affinity to wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	95.0	CHEMBL4849	Homo sapiens	Activity	%	95.0
	18892673	CHEMBL4314576	Inhibition of recombinant human NEK7 (2 to end residues) assessed as residual activity at 10 uM using FLAKSFGSPNRAYKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	106.5	CHEMBL4849	Homo sapiens	Activity	%	106.5
	18938149	CHEMBL4327801	Inhibition of human NEK7 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	94.15	CHEMBL4849	Homo sapiens	Activity	%	94.15
	18938150	CHEMBL4327801	Inhibition of human NEK7 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	98.28	CHEMBL4849	Homo sapiens	Activity	%	98.28
	18938646	CHEMBL4328165	Inhibition of human NEK7 assessed as residual activity at 100 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	<	Activity	%	65.0	CHEMBL4849	Homo sapiens	Activity	%	65.0
Not Determined	18939027	CHEMBL4328529	Inhibition of human NEK7 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		IC50			CHEMBL4849	Homo sapiens	IC50		
	18939028	CHEMBL4328529	Inhibition of human NEK7 using casein as substrate by [gamma-33P]-ATP assay	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	IC50	nM	7280.0	CHEMBL4849	Homo sapiens	IC50	10'-6M	7.28
	18958661	CHEMBL4333530	Binding affinity to wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	84.0	CHEMBL4849	Homo sapiens	Activity	%	84.0
	18964525	CHEMBL4335203	Inhibition of recombinant human NEK7 (2 to end residues) assessed as residual activity at 1 uM using FLAKSFGSPNRAYKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	107.0	CHEMBL4849	Homo sapiens	Activity	%	107.0
	18964526	CHEMBL4335203	Inhibition of recombinant human NEK7 (2 to end residues) assessed as residual activity at 1 uM using FLAKSFGSPNRAYKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	98.0	CHEMBL4849	Homo sapiens	Activity	%	98.0
	18972017	CHEMBL4337027	Inhibition of recombinant human NEK7 (2 to end residues) assessed as residual activity at 10 uM using FLAKSFGSPNRAYKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	119.0	CHEMBL4849	Homo sapiens	Activity	%	119.0
Not Active	19040075	CHEMBL4351979	Inhibition of recombinant human NEK7 (2 to end residues) at 10 uM using FLAKSFGSPNRAYKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4849	Homo sapiens	INH		
Active	19041209	CHEMBL4352470	Inhibition of human NEK7 at 10 uM using casein as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4849	Homo sapiens	INH		
	19059722	CHEMBL4358023	Binding affinity to wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	19090287	CHEMBL4365861	Inhibition of wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	19092039	CHEMBL4366513	Inhibition of human NEK7 at 100 nM using casein as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	4.12	CHEMBL4849	Homo sapiens	INH	%	4.12
	19144721	CHEMBL4377737	Inhibition of recombinant human NEK7 (2 to end residues) at 1 uM using FLAKSFGSPNRAY as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-6.0	CHEMBL4849	Homo sapiens	INH	%	-6.0
	19147963	CHEMBL4379249	Inhibition of recombinant human NEK7 (2 to end residues) using FLAKSFGSPNRAYKK as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4849	Homo sapiens	IC50	uM	10.0
	19159550	CHEMBL4382654	Binding affinity to wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	72.0	CHEMBL4849	Homo sapiens	Activity	%	72.0
	19191457	CHEMBL4389373	Inhibition of wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	72.0	CHEMBL4849	Homo sapiens	INH	%	72.0
	19192036	CHEMBL4389850	Inhibition of wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	92.0	CHEMBL4849	Homo sapiens	INH	%	92.0
	19200292	CHEMBL4391476	Binding affinity to wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	27.0	CHEMBL4849	Homo sapiens	Activity	%	27.0
	19266536	CHEMBL4405486	Inhibition of wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4849	Homo sapiens	INH	%	50.0
	19276063	CHEMBL4408066	Inhibition of recombinant human NEK7 (2 to end residues) at 1 uM using FLAKSFGSPNRAYKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	3.0	CHEMBL4849	Homo sapiens	INH	%	3.0
	20600605	CHEMBL4603557	Inhibition of NEK7 (unknown origin) by Z'LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4849	Homo sapiens	IC50	uM	100.0
	22423397	CHEMBL4674274	Inhibition of human NEK7 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	105.51	CHEMBL4849	Homo sapiens	Activity	%	105.51
	22423398	CHEMBL4674274	Inhibition of human NEK7 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	92.5	CHEMBL4849	Homo sapiens	Activity	%	92.5
	22843987	CHEMBL4720973	Inhibition of human NEK7 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	88.18	CHEMBL4849	Homo sapiens	Activity	%	88.18
	22844798	CHEMBL4721473	Inhibition of wild-type human full length NEK7 (M1 to S302 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	97.66	CHEMBL4849	Homo sapiens	Activity	%	97.66
	22952928	CHEMBL4766865	Inhibition of recombinant human NEK7 (2 to end residues) assessed as residual activity at 10 uM using FLAKSFGSPNRAYKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	93.0	CHEMBL4849	Homo sapiens	Activity	%	93.0
Active	22994969	CHEMBL4775915	Binding affinity to NEK7 in PMA-differentiated human THP-1 cells incubated for 2 hrs by SDS-PAGE and LC-MS/MS analysis	B	COc1c(OCCOCCOCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL4787313		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Active	22994970	CHEMBL4775915	Binding affinity to NEK7 in PMA-differentiated human THP-1 cells incubated for 2 hrs by SDS-PAGE and LC-MS/MS analysis	B	COc1cc2c(cc1OC)-c1cc3ccc(OC)c(OCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)c3c[n+]1CC2.[Cl-]		CHEMBL4784456		Activity			CHEMBL4849	Homo sapiens	Activity		
Active	22994971	CHEMBL4775916	Binding affinity to DIM1 in PMA-differentiated human THP-1 cells incubated for 2 hrs by SDS-PAGE and LC-MS/MS analysis	B	COc1c(OCCOCCOCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL4787313		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Active	22994972	CHEMBL4775916	Binding affinity to DIM1 in PMA-differentiated human THP-1 cells incubated for 2 hrs by SDS-PAGE and LC-MS/MS analysis	B	COc1cc2c(cc1OC)-c1cc3ccc(OC)c(OCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)c3c[n+]1CC2.[Cl-]		CHEMBL4784456		Activity			CHEMBL4849	Homo sapiens	Activity		
Active	22994973	CHEMBL4775917	Binding affinity to NEK7 in PMA-differentiated human THP-1 cells incubated for 2 hrs by immunoblot analysis	B	COc1c(OCCOCCOCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL4787313		Activity			CHEMBL4849	Homo sapiens	Activity		
Active	22994974	CHEMBL4775918	Binding affinity to NEK7 in PMA-differentiated human THP-1 cells assessed as reduction in Cy3-labeled target proteins at 100 uM incubated for 8 hrs using probe-16 by fluorescent gel imaging analysis	B	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL12089		Activity			CHEMBL4849	Homo sapiens	Activity		
Active	22994975	CHEMBL4775919	Binding affinity to NEK7 in PMA-differentiated human THP-1 cells at 100 uM incubated for 8 hrs by streptavidin-bead enrichment and immunoblot assay	B	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL12089		Activity			CHEMBL4849	Homo sapiens	Activity		
Active	22994976	CHEMBL4775920	Binding affinity to human recombinant NEK7 incubated for 2 hrs by pull down assay	B	COc1c(OCCOCCOCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL4787313		Activity			CHEMBL4849	Homo sapiens	Activity		
Not Active	22994977	CHEMBL4775921	Binding affinity to human recombinant NEK7 incubated for 2 hrs in presence of BBR by pull down assay	B	COc1c(OCCOCCOCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL4787313		Activity			CHEMBL4849	Homo sapiens	Activity		
Dose-dependent effect	22994978	CHEMBL4775922	Binding affinity to human recombinant NEK7 incubated for 2 hrs by pull down assay relative to control	B	COc1c(OCCOCCOCCNC(=O)CCCC[C@@H]2SC[C@@H]3NC(=O)N[C@H]23)ccc2cc3[n+](cc12)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL4787313		Activity			CHEMBL4849	Homo sapiens	Activity		
	22994979	CHEMBL4775923	Inhibition of purified recombinant human NEK7 incubated for 15 mins before ATP and substrate addition and further incubated for 40 mins by ADPGlo kinase assay	B	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL12089	=	IC50	nM	4200.0	CHEMBL4849	Homo sapiens	IC50	uM	4.2
	22994980	CHEMBL4775924	Binding affinity to purified recombinant human NEK7 by SPR analysis	B	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL12089	=	Kd	nM	15600.0	CHEMBL4849	Homo sapiens	Kd	uM	15.6
	23120782	CHEMBL4804447	Inhibition of NEK7 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-20200.0	CHEMBL4849	Homo sapiens	IC50	uM	-20.2
	23120783	CHEMBL4804447	Inhibition of NEK7 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1	Outside typical range	CHEMBL4860979	=	IC50	nM	-10500.0	CHEMBL4849	Homo sapiens	IC50	uM	-10.5
	23120784	CHEMBL4804447	Inhibition of NEK7 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-8100.0	CHEMBL4849	Homo sapiens	IC50	uM	-8.1
	23120785	CHEMBL4804447	Inhibition of NEK7 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-63600.0	CHEMBL4849	Homo sapiens	IC50	uM	-63.6
	23120786	CHEMBL4804447	Inhibition of NEK7 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-80000.0	CHEMBL4849	Homo sapiens	IC50	uM	-80.0
	23120787	CHEMBL4804447	Inhibition of NEK7 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-39500.0	CHEMBL4849	Homo sapiens	IC50	uM	-39.5
	23121820	CHEMBL4804629	Inhibition of NEK7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL4849	Homo sapiens	INH	%	0.0
	23121821	CHEMBL4804629	Inhibition of NEK7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL4849	Homo sapiens	INH	%	0.0
	23121822	CHEMBL4804629	Inhibition of NEK7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4849	Homo sapiens	INH	%	0.0
	23121823	CHEMBL4804629	Inhibition of NEK7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL4849	Homo sapiens	INH	%	0.0
	23121824	CHEMBL4804629	Inhibition of NEK7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL4849	Homo sapiens	INH	%	0.0
	23121825	CHEMBL4804629	Inhibition of NEK7 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL4849	Homo sapiens	INH	%	0.0
	23122707	CHEMBL4805058	Inhibition of human NEK7 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	94.0	CHEMBL4849	Homo sapiens	Activity	%	94.0
	23123402	CHEMBL4805646	Inhibition of human NEK7 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	89.0	CHEMBL4849	Homo sapiens	Activity	%	89.0
	23123860	CHEMBL4806104	Inhibition of DNA-tagged human NEK7 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	59.0	CHEMBL4849	Homo sapiens	Activity	%	59.0
	23124894	CHEMBL4806663	Inhibition of human NEK7 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4849	Homo sapiens	Activity	%	100.0
	23124895	CHEMBL4806663	Inhibition of human NEK7 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	86.0	CHEMBL4849	Homo sapiens	Activity	%	86.0
	23128377	CHEMBL4807934	Inhibition of NEK7 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4849	Homo sapiens	Activity	%	75.0
	23128378	CHEMBL4807934	Inhibition of NEK7 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4849	Homo sapiens	Activity	%	75.0
	23128379	CHEMBL4807934	Inhibition of NEK7 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4849	Homo sapiens	Activity	%	75.0
Not Active	23317543	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	85.0	CHEMBL4849	Homo sapiens	% Control	%	85.0
Not Active	23318011	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Slightly Active	23318865	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	46.0	CHEMBL4849	Homo sapiens	% Control	%	46.0
Not Active	23318866	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794	>	Kd	nM	10000.0	CHEMBL4849	Homo sapiens	Kd	nM	10000.0
Not Active	23319161	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	99.0	CHEMBL4849	Homo sapiens	% Control	%	99.0
Not Active	23319798	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23320273	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	86.6	CHEMBL4849	Homo sapiens	% Control	%	86.6
Not Active	23320951	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23321419	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23322049	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	96.0	CHEMBL4849	Homo sapiens	% Control	%	96.0
Not Active	23322517	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23323206	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23323674	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23324077	CHEMBL4880696	NEK7 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-12.0	CHEMBL4849	Homo sapiens	% inhibition	%	-12.0
Not Active	23324528	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	87.4	CHEMBL4849	Homo sapiens	% Control	%	87.4
Not Active	23325163	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23325631	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23326278	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	86.0	CHEMBL4849	Homo sapiens	% Control	%	86.0
Not Active	23326746	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	90.0	CHEMBL4849	Homo sapiens	% Control	%	90.0
Not Active	23327446	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23327914	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	65.0	CHEMBL4849	Homo sapiens	% Control	%	65.0
Not Active	23328501	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	99.0	CHEMBL4849	Homo sapiens	% Control	%	99.0
Not Active	23328969	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23329449	CHEMBL4881156	NEK7(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	106.0	CHEMBL4849	Homo sapiens	% residual kinase activity	%	106.0
Not Active	23329915	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23330383	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23331139	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23331607	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23332194	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	75.5	CHEMBL4849	Homo sapiens	% Control	%	75.5
Not Active	23332660	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23333378	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23334017	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23334485	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23335464	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23335932	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23336559	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	83.0	CHEMBL4849	Homo sapiens	% Control	%	83.0
Not Active	23337027	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23337696	CHEMBL4882067	NEK7 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	99.0	CHEMBL4849	Homo sapiens	% Ctrl	%	99.0
Not Active	23338108	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	90.0	CHEMBL4849	Homo sapiens	% Control	%	90.0
Not Active	23338576	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23339188	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23339656	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	95.0	CHEMBL4849	Homo sapiens	% Control	%	95.0
Not Active	23340293	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23340761	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	90.0	CHEMBL4849	Homo sapiens	% Control	%	90.0
Not Active	23341418	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23341886	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23342502	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	98.0	CHEMBL4849	Homo sapiens	% Control	%	98.0
Not Active	23342970	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23343600	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23344068	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	98.0	CHEMBL4849	Homo sapiens	% Control	%	98.0
Not Active	23344706	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23345279	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23345747	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23346324	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	92.9	CHEMBL4849	Homo sapiens	% Control	%	92.9
Not Active	23346792	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	75.7	CHEMBL4849	Homo sapiens	% Control	%	75.7
Not Active	23347394	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	76.9	CHEMBL4849	Homo sapiens	% Control	%	76.9
Not Active	23347884	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	98.0	CHEMBL4849	Homo sapiens	% Control	%	98.0
Not Active	23348463	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23348931	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23349518	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23350136	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23350604	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23351209	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23351677	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	98.0	CHEMBL4849	Homo sapiens	% Control	%	98.0
Not Active	23352149	CHEMBL4882838	NEK7 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	3.683	CHEMBL4849	Homo sapiens	% Inhibition	%	3.6828
Not Active	23352701	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23353169	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	79.0	CHEMBL4849	Homo sapiens	% Control	%	79.0
Not Active	23354051	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23354519	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23355251	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23355719	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23356355	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23356823	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23357432	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23358079	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23358547	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23359133	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23359731	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	97.0	CHEMBL4849	Homo sapiens	% Control	%	97.0
Not Active	23360199	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	89.0	CHEMBL4849	Homo sapiens	% Control	%	89.0
Not Active	23360784	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23361252	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	96.0	CHEMBL4849	Homo sapiens	% Control	%	96.0
Not Active	23361825	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	97.0	CHEMBL4849	Homo sapiens	% Control	%	97.0
Not Active	23362361	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	97.0	CHEMBL4849	Homo sapiens	% Control	%	97.0
Not Active	23362829	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	98.0	CHEMBL4849	Homo sapiens	% Control	%	98.0
Not Active	23364471	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	82.0	CHEMBL4849	Homo sapiens	% Control	%	82.0
Not Active	23364939	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	97.0	CHEMBL4849	Homo sapiens	% Control	%	97.0
Not Active	23365678	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	99.0	CHEMBL4849	Homo sapiens	% Control	%	99.0
Not Active	23366221	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	94.0	CHEMBL4849	Homo sapiens	% Control	%	94.0
Not Active	23366811	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	99.0	CHEMBL4849	Homo sapiens	% Control	%	99.0
Not Active	23367279	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	97.0	CHEMBL4849	Homo sapiens	% Control	%	97.0
Not Active	23367673	CHEMBL4884026	NEK7 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	83.0	CHEMBL4849	Homo sapiens	% Residual activity with Skepinone-L	%	83.0
Not Active	23368157	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	84.0	CHEMBL4849	Homo sapiens	% Control	%	84.0
Not Active	23368625	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	82.0	CHEMBL4849	Homo sapiens	% Control	%	82.0
Not Active	23369224	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23369692	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23370167	CHEMBL4884409	NEK7(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	112.0	CHEMBL4849	Homo sapiens	% residual kinase activity	%	112.0
Not Active	23370660	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	83.0	CHEMBL4849	Homo sapiens	% Control	%	83.0
Not Active	23371128	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	96.0	CHEMBL4849	Homo sapiens	% Control	%	96.0
Not Active	23371937	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23372405	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	88.0	CHEMBL4849	Homo sapiens	% Control	%	88.0
Not Active	23375322	CHEMBL4886304	NIMA -related kinase 7 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	2.0	CHEMBL4849	Homo sapiens	% inhibition	%	2.0
Not Active	23375832	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	87.0	CHEMBL4849	Homo sapiens	% Control	%	87.0
Not Active	23376300	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23376877	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	75.0	CHEMBL4849	Homo sapiens	% Control	%	75.0
Not Active	23377345	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	68.0	CHEMBL4849	Homo sapiens	% Control	%	68.0
Not Active	23378205	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	91.0	CHEMBL4849	Homo sapiens	% Control	%	91.0
Not Active	23378673	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23379840	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23380308	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	82.0	CHEMBL4849	Homo sapiens	% Control	%	82.0
Not Active	23381002	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23381650	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23382118	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4849	Homo sapiens	% Control	%	100.0
Not Active	23382742	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	70.0	CHEMBL4849	Homo sapiens	% Control	%	70.0
Not Active	23383210	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	68.0	CHEMBL4849	Homo sapiens	% Control	%	68.0
Not Active	23384055	CHEMBL4887653	NEK7 DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	104.0	CHEMBL4849	Homo sapiens	% Ctrl	%	104.0
Not Active	23384381	CHEMBL4887976	NEK7(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	5.49	CHEMBL4849	Homo sapiens	% inhibition	%	5.49
Not Active	23385125	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	75.0	CHEMBL4849	Homo sapiens	% Control	%	75.0
Not Active	23385592	CHEMBL4879849	KinomeScan assay: inhibition of NEK7	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	91.0	CHEMBL4849	Homo sapiens	% Control	%	91.0
